| 09.03.2010 | HealthHelp Enhances Diagnostic Cardiology Services
HealthHelp, a leading specialty benefit management provider, continues
to target health care cost drivers by adding diagnostic cardiac
catheterization to its well-established and effective suite of services.
| More... |
| 09.03.2010 | Venn Life Sciences Appoints New VP Business Development
Venn
Life Sciences would like to announce the appointment of Dale Trask
as Vice President Global Business Development, marking an important
phase in the company's growth. Mr. Trask brings extensive experience in
Clinical Research Organisation (CRO) business development and will be
responsible for enhancing Venn's business partnerships, strategic
relationships and growth into new markets.
| More... |
| 09.03.2010 | Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that
it has received from the Food and Drug Administration (FDA) an
Investigational Device Exemption (IDE) approval to initiate a pivotal
Phase III clinical trial upon obtaining institutional review board (IRB)
approval from the clinical sites, using the Company's Microfocus APA
1000 System for the treatment of breast cancer. Medifocus had already
announced on June 9, 2009 that Health Canada had granted full
Investigational Testing Authorization (ITA) approval to allow the
initiation of the same pivotal Phase III study in Canada.
| More... |
| 09.03.2010 | Mayo Researchers Link Obesity to Worse Outcome in Patients Being Treated for Colon Cancer
It's long been known that obesity is linked to increased risk of
developing colon cancer, but now researchers at the Mayo Clinic campus
in Minnesota have found that obesity is associated with worse outcomes
in patients who have already been diagnosed and treated for the cancer.
| More... |
| 09.03.2010 | Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for OR Equipment Drapes
| More... |
| 09.03.2010 | Rosetta Genomics to Present at the 22nd Annual Roth OC Growth Stock Conference
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of
microRNA-based molecular diagnostics, announced that Kenneth A. Berlin,
president and chief executive officer, will be presenting a corporate
update at the 22nd Annual Roth OC Growth Stock Conference on Tuesday,
March 16, 2010 at 3:30 p.m. (Pacific Time) at the Ritz Carlton Laguna
Niguel in Dana Point, California.
| More... |
| 09.03.2010 | Inhibitex to Host Conference Call to Report Fourth Quarter and Year-End 2009 Financial Results on March 23, 2010
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a
conference call on Tuesday, March 23, 2010 at 9:00 a.m. EST to review
the Company's fourth quarter and year-end December 31, 2009 financial
results and provide an update on recent corporate developments. The
Company will issue a press release regarding its financial results on
the same day, prior to the conference call.
| More... |
| 09.03.2010 | Alnylam to Webcast Presentation at the 22nd Annual ROTH OC Growth Stock Conference
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi
therapeutics company, today announced that management will present a
company overview at the 22nd Annual ROTH OC Growth Stock
Conference on Tuesday, March 16, 2010, at 3:00 p.m. PT (6:00 p.m. ET) at
the Ritz-Carlton, Laguna Niguel in California.
| More... |
| 09.03.2010 | Medical Compressions Systems Expands U.S. Operations and Appoints Industry Veteran to Newly Created Role of President
Medical Compression Systems, Ltd. (TASE:MDCL), a company specializing in
innovative non-invasive blood circulation solutions, today announced the
appointment of Ambaw Bellete to the position of president of its U.S.
subsidiary, Medical Compression Systems, Inc. Mr. Bellete brings with
him more than 20 years of management experience from executive positions
in business development, marketing and sales in the medical device and
pharmaceutical industries with an emphasis on thrombosis, cardiology,
immunology and cardiology. Most recently, Ambaw served as vice president
at Sanofi Aventis for the Orthopedic and Urology Franchise business
including leading the commercial efforts in orthopedics for Lovenox®
(enoxaparin sodium injection).
| More... |
| 09.03.2010 | Pernix To Present At Cowen and Company Health Care Conference
Pernix Therapeutics Holdings, Inc. (NYSE Amex:PTX) ("the Company") today
announced that the Company will present at the Cowen and Company 30th
Annual Health Care Conference at the Marriott Copley Place in Boston.
| More... |
| 09.03.2010 | Recent Studies Link Obesity to Food Allergies
First Lady Michelle Obama's "Let's Move" Campaign tells us that about 32
percent of children and teens (or 25 million) are obese or overweight.
It revealed those extra pounds put them at greater risk of developing
debilitating and costly diseases including diabetes, high blood pressure
and high cholesterol and may also cause them to lead a two to five year
shorter life than their parents.
| More... |
| 09.03.2010 | BioSante Pharmaceuticals Closes $18 Million in Registered Direct Offering
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the
closing of the sale, directly to funds affiliated with two institutional
investors, of an aggregate of approximately 10.4 million shares of
BioSante's common stock and warrants to purchase up to approximately 5.2
million shares of its common stock, resulting in gross cash proceeds to
BioSante of $18 million. The investors are Great Point Partners, LLC and
Deerfield Management Company. BioSante received net proceeds of
approximately $17.5 million after deducting placement agent fees and
other estimated offering expenses. Each unit, consisting of one share of
common stock and a warrant to purchase 0.5 of a share of common stock,
was sold for a purchase price of $1.73, which is equal to the closing
price of BioSante's common stock on the day before the securities
purchase agreements were signed, as reported by the NASDAQ Stock Market.
| More... |
| 09.03.2010 | Hewitt Survey Shows Employers Continuing to Invest in Health of Workers Despite Uncertainty of Future Health Care Landscape
Despite the uncertainty of health care reform, most U.S. employers say
they are continuing to make investments today that will improve the
long-term health and productivity of their workforce, according to a new
survey by Hewitt Associates, a global human resources consulting and
outsourcing company. But while well-intentioned, Hewitt's survey shows
most companies are just beginning to consider and implement the types of
strategies, tactics and goals that will create positive and sustainable
improvements in employee health and constrain escalating health care
costs.
| More... |
| 09.03.2010 | QuadraMed Stockholder Meeting to be Held on March 9, 2010; Delaware Chancery Court Denies Preliminary Injunction
QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of
healthcare information technologies and services that help turn quality
care into positive financial outcomes, announced today that on March 8,
2010, the Court of Chancery of the State of Delaware issued an opinion
denying LC Capital Master Fund, Ltd.'s motion for a preliminary
injunction of QuadraMed's proposed acquisition by Francisco Partners.
| More... |
| 09.03.2010 | Research and Markets: Consumer Health: New Product Developments in 2009/2010
| More... |
| 09.03.2010 | Corporate Translations Chooses Across Systems Software to Increase Productivity and Reduce Cost in Life Science Translation Projects
Corporate Translations, Inc., a leading translation service provider
specializing in the life science industry, has recently switched from
Trados to the Across
Language Server for its translation
management software. The company indicates that the Across
technology better meets its core values of speed, accuracy, flexibility
and innovation; Corporate Translations will move all of its suitable
translation projects to the Across Language Server over the course of
2010.
| More... |
| 09.03.2010 | Research and Markets: "Neuro and Musculoskeletal Imaging Program" - Participants Should Gain Familiarity of Up-To-Date Imaging Protocols, As Well As, Imaging Pitfalls
| More... |
| 09.03.2010 | William A. Hawkins, Medtronic Chairman and CEO, Receives Distinguished Achievement Award from Biomedical Engineering Society
Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins,
chairman and CEO, recently received the Biomedical Engineering Society's
Distinguished Achievement Award. As part of the award, the plenary
lecture he delivered to the organization was published in the March 2010
edition of the Annals of Biomedical Engineering. The
Distinguished Achievement Award is given to a company, charitable
foundation, or nonacademic institution that has made great contributions
to the field of biomedical engineering/bioengineering.
| More... |
| 09.03.2010 | biospace med Signs Distribution Agreement with Odelft for Benelux
biospace med (www.biospacemed.com),
an emerging medical technology company based in Paris, and Oldelft
Benelux, a renowned specialist in medical diagnostic imaging,
announced today the signature of an exclusive distribution agreement of EOS,
the world's first ultra-low-dose 2D|3D imager. The
agreement will cover the distribution of EOS for the Benelux area
(Belgium, The Netherlands & Luxembourg).
| More... |
| 09.03.2010 | Fitch Affirms Amgen's IDR at 'A'; Rates New Issuance 'A'; Outlook Stable
Fitch Ratings has affirmed Amgen Inc. (Amgen) ratings as follows:
| More... |
| 09.03.2010 | Research and Markets: US Markets for Reprocessed Devices 2009 - Observe the Rising Penetration of Reprocessed Devices and the Revenue Losses Of OEMs Through 2013
| More... |
| 09.03.2010 | Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that
its Board of Directors received a letter from Mr. Eli Hurvitz indicating
that he wishes to be released from his duties at Teva in order to focus
on his full recovery. Accordingly, Professor Moshe Many has stepped down
from his role as Interim Chairman and following deliberations held by
the Board of Directors and in accordance with the recommendation of the
Nomination Committee, the Board has unanimously appointed its Vice
Chairman, Dr. Phillip Frost, to serve as Chairman of the Board of
Directors.
| More... |
| 09.03.2010 | Provectus Pharmaceuticals Executes Purchase Agreements for Approximately $5.3 Million Private Placement
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage
oncology and dermatology biopharmaceutical company, announced today that
it has signed agreements with various institutional and accredited
investors for the private placement of an aggregate of approximately 7.1
million shares of its convertible preferred stock and warrants to
purchase approximately 3.55 million shares of its common stock at an
exercise price of $1.00 per share pursuant to a Securities Purchase
Agreement. The Company will receive gross proceeds of $5.3 million. The
shares to be issued to the investors and the shares underlying the
warrants have not been and will not be registered under the Securities
Act of 1933, and may not be offered or sold in the United States absent
registration or an applicable exemption from registration requirements.
| More... |
| 09.03.2010 | Digestive CARE is Seeking Online Votes for Top Colonscopy-Related Song Titles During National Colorectal Cancer Awareness Month
Digestive CARE, a medical group of more than 50
gastroenterologists in Broward and Palm Beach County, today announced
that it is receiving hundreds of online votes in its "Bottom Line
Song Title Contest" to bring awareness to National Colorectal
Cancer Awareness Month (March 2010).
| More... |
| 09.03.2010 | Exelixis Announces Fourth Quarter and Full Year 2009 Financial Results
Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the
fourth quarter and year ended December 31, 2009.
| More... |
| 09.03.2010 | Research and Markets: Growth Opportunities for Left Ventricular Assist Devices (LVAD) in Heart Failure Market
| More... |
| 09.03.2010 | FreeSlate, Inc. Launch Enables Step-Change Gains in Productivity and Innovation for R&D Organizations
Today, FreeSlate, Inc. announced its launch as an independent company
focused on delivering integrated workflow solutions for R&D
organizations seeking to maximize productivity and enhance innovation.
FreeSlate, which previously operated as the High Productivity Research
(HPR) business unit of Symyx Technologies, provides researchers with
increased experimental capacity and faster decision-making via its
microscale, high-throughput technology, lab execution and analysis
software, and experienced engineers and application scientists.
| More... |
| 09.03.2010 | PHC Says New Adolescent Units at Seven Hills Behavioral Institute To Add EPS of 3 Cents Per Share in CEOcast.com Interview
CEOcast.com., a financial portal providing coverage of emerging growth
companies, announced today that it conducted an online interview with
Bruce A. Shear, president and CEO of PHC, Inc., d/b/a Pioneer Behavioral
Health (NYSE Amex: PHC), , a leading provider of inpatient and
outpatient behavioral health services. In the interview, Mr. Shear
discussed the company's recent decision to open a ten-bed adolescent
unit at its Seven Hills Behavioral Institute (SHBI) in Henderson,
Nevada. The Hospital provides psychiatric, alcohol and drug addiction
treatment for adolescents and adults. Mr. Shear noted that he expects
the new Unit to generate $2 million in annual revenue and strong
operating margins, which are expected to generate an incremental 3 cents
per share in annual earnings. For the first six months of its fiscal
year ended December 31, 2009, PHC earned 3 cents per share.
| More... |
| 09.03.2010 | Bond Labs Expands Nebraska Coverage with Another Anheuser-Busch® Distributor for Resurrection
Bond Laboratories, Inc. (OTCBB:BNLB),
a manufacturer of innovative nutritional supplements and functional
beverages, today announced the addition of another Anheuser-Busch®
distributor to its Fusion Premium Beverages' products distribution
network. Quality Brands of Omaha Inc., the largest beer distributor in
the state of Nebraska, provides Fusion Premium Beverages with access to
more than 1,100 on and off premise accounts throughout the Omaha
territory they service.
| More... |
| 09.03.2010 | EHSI: Healthcare Sector Continues Growth by Adding 12,000 Jobs
Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI). The healthcare
industry continued its strong trend towards growth by adding 12,000 jobs
in February, according to US Bureau of Labor Statistics. Total
seasonally adjusted employment for healthcare, which includes hospitals,
ambulatory care centers, nursing facilities and residential care
facilities, was 13.67 million up from 13.65 million in January of 2010.
| More... |
| 09.03.2010 | Ministry Health Care Selects Aternity's Application Performance Management Platform
Aternity Inc., the industry's technology leader in end
user experience management solutions for Global 1000 enterprises,
announced today that Ministry Health Care, a values-driven health care
delivery network of aligned hospitals, clinics and other providers, has
selected the Aternity
Frontline Performance Intelligence (FPI) Platform for its strategic
end user experience management initiatives. With Aternity, Ministry
Health Care is monitoring and analyzing the performance of its
Electronic Health Record (EHR) systems including GE Centricity® EMR and
CattailsMD EHR.
| More... |
| 09.03.2010 | Campbell Recognizes Employees for Taking Charge of Their Health
Campbell Soup Company (NYSE:CPB) today announced three winners of
the company's "Lifestyle Change Award," a program designed to recognize
employees who have made healthy lifestyle changes, positively influenced
others to improve their health or achieved a health-related goal.
| More... |
| 09.03.2010 | Association of Hole in the Wall Camps and the Hole in the Wall Foundation Name New President and CEO
The Association of Hole in the Wall Camps and the Hole in the Wall
Foundation are pleased to announce the appointment of John Reid as their
new President and CEO. John assumes the role from Ray Empson who is
retiring from the organization.
| More... |
| 09.03.2010 | Neoprobe to Present at Roth Capital Partners 22nd Annual OC Growth Stock Conference
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of
innovative oncology surgical and diagnostic products, today announced
that its President and CEO, David Bupp, will present at the Roth Capital
Partners 22nd Annual OC Growth Stock Conference on Monday,
March 15, 2010 at 4:00 PM PST. The conference is taking place at the
Ritz-Carlton in Laguna Niguel, CA. Mr. Bupp will provide a corporate
overview, including an update and discussion of the clinical and
regulatory status of Neoprobe's two drug development products, Lymphoseek®
and RIGScan CR.
| More... |
| 09.03.2010 | Xplore Introduces "Clean Room" iX104C4 Tablet PC
Xplore Technologies Corp. (OTCBB: XLRT), a maker of award-winning rugged
mobile computers, today announced the launch of a new unit specifically
designed for use in clean rooms. "The Clean Room iX104C4 Tablet PC
represents a significant opportunity for Xplore and is an application of
our technology that we believe will deliver significant value to clean
room users," said Mark Holleran, President and Chief Operating Officer
of Xplore Technologies. Xplore is a leader in fully rugged tablet PCs
according to industry reports.
| More... |
| 09.03.2010 | Research and Markets: Report Finds European Markets for Acute Care Clinical Information Systems to Grow Despite Global Downturn
| More... |
| 09.03.2010 | Sartorius zieht Bilanz für das Geschäftsjahr 2009
Sartorius (FWB:SRT), ein international führender Labor- und
Prozess-ausstatter, hat seinen operativen Gewinn im Jahr 2009 trotz der
schwierigen gesamt-wirtschaftlichen Rahmenbedingungen gesteigert und ein
operatives Ergebnis von 60,9 Mio. Euro nach 56,8 Mio. Euro im Vorjahr
erzielt. "Damit zählen wir zu den Unternehmen, die das Krisenjahr 2009
mit einer positiven operativen Ertragsentwicklung abschließen konnten",
kommentierte Konzernchef Dr. Joachim Kreuzburg die Jahresergebnisse auf
der Bilanzpressekonferenz in Göttingen.
| More... |
| 09.03.2010 | Initial Edit of The Complete Package Reality Television Show Exceeds Expectations as Media Interest Accelerates
Muscle Flex Inc. (www.MuscleFlex.com)
(Pink Sheets:MFLI) announced today that it has reviewed the first edits
of The Complete Package (www.TheCompletePackageTV.com)
Reality TV Show pilot and opening episode as well as the two-minute
sizzle reel and has exceeded its expectations in every measure. TLK
Fusion (www.TLKFusion.com),
BRAVADA / Muscle Flex's partner in The Complete Package which includes
Wesley Morris Entertainment (www.WesleyMorris.com),
have been engaged in substantive discussions with a number of high
profile Hollywood entities and power brokers with regards to The
Complete Package and have received a tremendous degree of interest. As
well, a growing list of high profile national media and nationally
syndicated talk shows and programs have requested and are awaiting
copies of the two-minute Complete Package sizzle reel which shall be
released to the media and the public. The release date of The Complete
Package sizzle reel is expected the week of March 15th.
| More... |
| 09.03.2010 | Mitsubishi Chemical Medience Corporation Switches to Provantis
Instem, a leading provider of early drug development software solutions,
announced today that Mitsubishi Chemical Medience Corporation (MCM) has
purchased the Provantis preclinical software solution.
| More... |
| 09.03.2010 | Morinaga Milk Industry Co., Ltd. Receives No Objection Letter from FDA Regarding GRAS Status of Proprietary Probiotic Strain, Bifidobacterium longum BB536
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second-largest dairy
company in Japan, today announced it has received a no objection letter
from FDA in response to its GRAS notification for the proprietary
probiotic strain Bifidobacterium longum BB536. The official FDA
affirmation that the ingredient is GRAS paves the way for the highly
researched probiotic to be included in functional foods.
| More... |
| 09.03.2010 | Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Bristol-Myers
Squibb Company (NYSE: BMY) and AstraZeneca
(NYSE: AZN) today announced the commencement of the "Saxagliptin
Assessment of Vascular
Outcomes Recorded
in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a
multicenter, randomized, double-blind, placebo-controlled Phase 4 study,
to evaluate treatment with ONGLYZA
(saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, in adult type
2 diabetes patients with cardiovascular risk factors. The five-year
study will follow approximately 12,000 patients with type 2 diabetes,
who have either a history of previous cardiovascular events or multiple
risk factors for vascular disease, and includes patients with renal
impairment.
| More... |
| 09.03.2010 | Medical Banking Rx Receives Disruptive Innovator Award
Medical
Banking Rx, LLC, a full service pharmacy benefit management (PBM)
firm, today announced that it has received the 2010 Healthcare
Information and Management Systems Society (HIMSS) Medical Banking
Project Disruptive Innovator Award. The Disruptive Innovator Award was
in recognition of the development of Patient Driven RxSM, a
truly unique prescription drug program that provides real-time solutions
to the deficiencies inherent in the Consumer Driven Health (CDH) market.
The award was presented during the 8th National Medical
Banking Institute segment of the HIMSS 2010 Annual Conference, in
Atlanta, Georgia.
| More... |
| 09.03.2010 | Coromega® Sweetens Adult Omega-3 Supplement Line
Premier supplements maker Coromega®
today unveiled Coromega Omega3 + Vitamin D, a delicious squeeze
supplement that provides a daily dose of omega-3s with added vitamin D3,
and Coromega Omega3 Fruit Gummies, a high-DHA chewable
gummy supplement for the kid in everyone.
| More... |
| 09.03.2010 | Newly Published Data Shows Chronix Biomedical's Serum DNA Assays Can Detect Early-Stage Breast Cancer
Chronix Biomedical today announced publication of a study that supports
the utility of its serum DNA blood tests for the early and accurate
detection of breast cancer. The Chronix tests detect the circulating DNA
that is released into the blood stream by damaged and dying cells. A
growing body of publications from Chronix and other researchers shows
that this circulating DNA can be identified and analyzed to provide a
diagnostic window into ongoing changes in the genome associated with
specific diseases—changes that can be used to identify disease processes
at an early stage and to track responses to treatment. This new study
shows that the Chronix approach was able to detect invasive breast
cancer with high diagnostic sensitivity and specificity, even at the
earliest stage when tumors are very small. The findings are published in
the current online edition of Molecular Cancer Research.*
| More... |
| 09.03.2010 | Helix BioMedix Announces $2.9 Million Funding Round
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides,
announced additional funding in the amount of $2.9 million through
convertible promissory notes. The company also announced the addition of
Lawrence Blake Jones to its board of directors.
| More... |
| 09.03.2010 | HST Global, Inc. Announces Continued Success with Dr. Forsythe's "FIT" Protocol
HST Global, Inc., (OTCBB: HSTC) today announced that Dr. James Forsythe,
MD, HMD, is experiencing continuous success with his Forsythe Immune
Therapy (FIT) Protocol. Dr. James Forsythe, MD, HMD, is a board
certified oncologist and a member of HST Global Inc.'s Board of
Directors and Scientific Advisory Board.
| More... |
| 09.03.2010 | Neurologix to Present at Roth Capital Partners 2010 OC Growth Stock Conference
Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the
development of innovative therapies for the brain and central nervous
system, announced today that Marc Panoff, the company's Chief Financial
Officer, will present at the Roth Capital Partners 22nd
Annual OC Growth Stock Conference. The conference will be held March 15
- 17 at The Ritz Carlton Laguna Niguel in Dana Point, CA.
| More... |
| 09.03.2010 | Critically Acclaimed Photographer and Museum Founder Donald Verger Donates "October Rose" Image to Susan G. Komen for the Cure®
Award-winning photographer Donald
Verger today announced that he is donating an extraordinary pink
rose image valued at $1,000 to support the Pink
Tie Ball, an annual event of the Maine Affiliate of
Susan G. Komen for the Cure, to be held March 20th at the
Holiday Inn by the Bay. Verger is also the Founder and President
Emeritus of the world-renowned Children's
Discovery Museum and Science
Discovery Museum in Massachusetts. He often donates his photography
works to nonprofit organizations that benefit families and children.
| More... |
| 09.03.2010 | $250,000 Bioactive Beverage Challenge Announced by Tahitian Noni International
Tahitian
Noni International (TNI) announced a new $250,000 Bioactive Beverage
Challenge to all makers of superfruit juices in the network marketing
industry. TNI believes that their Tahitian Noni® Original
Bioactive Beverage is so unique that no other product in the industry
will measure up to it.
| More... |
| 09.03.2010 | Accelr8 Announces Acceptance of Scientific Presentation, and Pilot Results with a New Rapid Test for a Major Emerging Resistance Threat
Accelr8 Technology Corporation (NYSE Amex: AXK) today announced
that it has received acceptance to present results for a study on
2-hour, culture-free, quantitative pathogen identification. The study
was co-authored with principal investigators at the Denver Health
Medical Center and the Barnes-Jewish Hospital in St. Louis. The
presentation will take place at the 110th General Meeting of the
American Society for Microbiology (ASM, www.asm.org)
to be held from May 23-27 in San Diego. Tests performed directly from
specimens accurately identified three target pathogens that are the most
resistanceprone bacteria responsible for hospital-acquired infections
(HAI).
| More... |
| 09.03.2010 | Vitacost.com, Inc. to Present at the Roth 22nd Annual OC Growth Stock Conference
Vitacost.com, Inc. (NASDAQ: VITC), a leading online retailer and direct
marketer of health and wellness products, today announced Ira Kerker,
the Company's Chief Executive Officer, and Richard Smith, the Company's
Chief Financial Officer will participate in the Roth 22nd Annual OC
Growth Stock Conference on March 16, 2010 at the Ritz-Carlton, in Laguna
Niguel, CA.
| More... |
| 09.03.2010 | PacificHealth Laboratories Partners with Saddleback Ltd. in the United Kingdom
PacificHealth Laboratories, Inc. (OTCBB: PHLI), a nutrition technology
company, today announced that it has partnered with Saddleback Ltd. to
distribute ACCELERADE products in the United Kingdom ("UK") to the
cycle sport industry.
| More... |
| 09.03.2010 | Expert Consortium Launches Chemistry Playbook®, Expedited CMC Solutions From Cambridge Major Laboratories, Xcelience, Beckloff Associates, and Avantium Pharma
Cambridge Major Laboratories, Inc., Avantium Pharma, Xcelience,
LLC and Beckloff Associates have formed a consortium of expert
client-focused companies to launch Chemistry Playbook®, an expedited
CMC solutions program designed to accelerate drug development.
| More... |
| 09.03.2010 | Healthways to Present at the Barclays Capital 2010 Global Healthcare Conference
Healthways, Inc. (NASDAQ: HWAY) will participate in the Barclays Capital
2010 Global Healthcare Conference to be held March 23-24, 2010, in
Miami, Florida. Ben R. Leedle, Jr., Healthways chief executive officer,
will present at the conference at 1:30 p.m. EDT (12:30 p.m. CDT),
Tuesday, March 23, 2010. The presentation and presentation materials
will be available live online and also for replay on the "Investors"
section of the Company's website, www.healthways.com.
Please go to the site at least 15 minutes prior to the presentation to
download and install any necessary audio software.
| More... |
| 09.03.2010 | Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that David P.
Southwell has been named Executive Vice President and Chief Financial
Officer. He will report directly to H. Thomas Watkins, President and
Chief Executive Officer, and will serve as a member of the Management
Committee of the Company. Mr. Southwell has served as a member of the
HGS Board of Directors since July 2008, and he is resigning from the
Board to accept this new position. His new appointment is effective
March 22, 2010.
| More... |
| 09.03.2010 | Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine
design, development and delivery, announced today that Dr. J. Joseph
Kim, President and CEO, will present at Roth Capital Partners' 22nd
Annual OC Growth Stock Conference on Monday, March 15th at
9:00 a.m. PT (12:00 noon ET). The conference is being held March 15-17,
2010, in Dana Point, California.
| More... |
| 09.03.2010 | MedAssets Inks Agreement for National Hospice Provider, Odyssey HealthCare, to Implement its Revenue Cycle Management Solutions for Business Office Efficiency and Cash Flow Improvement
MedAssets (NASDAQ: MDAS) announced today that Dallas-based Odyssey
HealthCare, Inc. (NASDAQ: ODSY), one of the largest providers of hospice
care in the United States, has signed a multi-year agreement to use
MedAssets' Web-based revenue
cycle management solutions to improve cash flow and business office
efficiency and to ensure reimbursement integrity.
| More... |
| 09.03.2010 | BioDelivery Sciences to Present at the 22nd Annual ROTH OC Growth Stock Conference
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today
that Dr. Mark A. Sirgo, President and Chief Executive Officer, will
present at the ROTH Capital Partners 22nd Annual OC Growth
Stock Conference at The Ritz-Carlton, Laguna Niguel in Dana Point,
California. The presentation is scheduled for Monday, March 15 at 11:00
AM Pacific Time.
| More... |
| 09.03.2010 | Supplement Maker Wins Verdict over Imitator in Federal Court
After a seven-day trial, a federal jury in Colorado rendered a verdict
finding that Allergy Research Group (ARG), a subsidiary of the Kikkoman
Corp. (OTC: KIKOF.PK), violated Federal false advertising laws in
marketing their product, "Russian Choice Immune," as identical to the
immune system support supplement Del-Immune V®, previously
marketed by ARG as Delta-Immune. The jury also determined that ARG
misled buyers as to the product's origin Russian Choice Immune was
actually developed and manufactured in Vietnam then sent it to the
U.S. without conducting any prior research, according to the testimony
of ARG's own expert, Dr. Ba Hoang.
| More... |
| 09.03.2010 | Care Communications, Inc. President Patty Thierry Sheridan Named a Candidate for President-elect of the American Health Information Management Association
Care
Communications, Inc., a nationally recognized leader in the health
information management (HIM) industry, announced today that its
president, Patty Thierry Sheridan, MBA, RHIA, has been nominated for the
role of President-elect of the American Health Information Management
Association (AHIMA). The election will take place June 7-25, 2010.
| More... |
| 09.03.2010 | BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced pre-clinical data
the Company will present at 1:15 CST today at the 2010 Orthopedic
Research Society (ORS) meeting in New Orleans. The Company's sports
medicine team will present results of two pre-clinical studies
demonstrating that rhPDGF-BB, in combination with tissue specific matrix
materials, promotes healing in tendon-tendon and tendon-bone injuries.
In addition, in vitro data demonstrating rhPDGF-BB's ability to
stimulate tenocytes (tendon cells) will also be presented.
| More... |
| 09.03.2010 | Safeguard Scientifics Launches Corporate Blog
Safeguard
Scientifics, Inc. (NYSE: SFE), a holding company that builds value
in growth-stage life
sciences and technology
companies, today launched its corporate blog at blog.safeguard.com.
The blog offers insights into Safeguard's strategy, performance and
perspectives on the markets, as well as developments at Safeguard's
partner companies.
| More... |
| 09.03.2010 | AbleNet International Business VP, Adam Wing is Presenting Latest Assistive Technology Solutions at REHAB Dubai 2010 Conference and Dubai Autism Center
AbleNet, Inc. USA's Vice President of International Business, Adam
Wing, will be making two presentations in Dubai. The Dubai Autism Center
and the Dubai International Rehabilitation Forum have Wing presenting on
March 16, 2010 on assistive technology solutions for those with a broad
range of disability.
| More... |
| 09.03.2010 | Researchers Identify Previously Unrecognized Genetic Disorder
Researchers from four laboratories that perform diagnostic genetic
testing of chromosome abnormalities in individuals with unexplained
physical and developmental disabilities recently identified a previously
unrecognized genetic disorder.
| More... |
| 09.03.2010 | Nat'l AHF/Magic Johnson HIV Testing Tour Arrives in Charlotte
| More... |
| 09.03.2010 | Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2009
Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV) recently reported its
audited financial results for the full year and quarter ending December
31, 2009.
| More... |
| 09.03.2010 | Lantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta
Lantheus
Medical Imaging, Inc., a worldwide leader in diagnostic imaging,
today announced that new data for BMS747158, the company's novel drug
candidate in clinical development as a Positron Emission Tomography
(PET) perfusion imaging agent, will be featured in an oral presentation
at the American
College of Cardiology 59th Annual Scientific Session
taking place March 14-16, 2010 in Atlanta. BMS747158 is now known by the
generic name flurpiridaz F 18. In addition, new data on LMI1195, the
company's innovative PET imaging agent in clinical studies for heart
failure, will be highlighted in a poster presentation.
| More... |
| 09.03.2010 | Medex Inc. Appoints Larry G. Shea Chief Operating Officer
Medex Inc. (MDXX:PK), today announced the appointment of Larry G. Shea
to the position of Chief Operating Officer and member of the Company's
board of directors.
| More... |
| 09.03.2010 | Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury
Ischemix
today announced the initiation of patient accrual in a multi-center
Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative
ischemia-reperfusion injury in patients undergoing elective percutaneous
coronary intervention (PCI) procedures. CMX-2043 is a cardio-protective
drug that combines Akt pathway-mediated cell survival effects and
anti-oxidant activity in a single small molecule.
| More... |
| 09.03.2010 | ClearCount Medical Solutions Appoints David Haffner as CFO
ClearCount
Medical Solutions, an innovator of patient safety solutions for the
operating room, today announced that it has appointed David Haffner as
its Chief Financial Officer. In this role, Mr. Haffner will oversee the
day-to-day financial operations of the company, and will be responsible
for the financial strategy as the company's product sales increase.
| More... |
| 09.03.2010 | BioImagene Introduces the iSlideTM to Enhance the Transition from Manual to Digital Pathology
BioImagene,
Inc., the leading provider of end-to-end digital
pathology solutions, today announced the availability of the iSlide
input device, an innovative device that allows pathologists to use a
microscope-like interface to manipulate digital images of slides.
| More... |
| 09.03.2010 | In U.S. Imaging First, Prenatal MRI Detects Rare Genetic Disease in Newborn
In a case believed to be a United States first, the radiology team at
Lucile Packard Children's Hospital has used prenatal magnetic resonance
imaging to detect an often-misdiagnosed genetic disease.
| More... |
| 09.03.2010 | YoNaturals Calls for Healthier Snack Vending in Nation's Schools
Leading natural and organic snack food vender YoNaturals is receiving
new support in its mission to replace junk foods and sugary beverages
with healthier vended choices in our nation's schools.
| More... |
| 09.03.2010 | RFM Secures Multi-Year Agreement with a Major Medical Equipment Manufacturer
RF Monolithics, Inc. (NASDAQ: RFMI) ("RFM") a leader in
machine-to-machine (M2M) wireless communications announced today that it
has secured a multi-year agreement with a major medical equipment
manufacturer for its ultra-low power short-range radio, the Virtual
Wire transceiver. The product has taken several years to attain various
levels of qualification and is now in volume production. The agreement
sets forth the customer's intent to continue use of this product, in
volume, for the next 5 years. The terms of this supply agreement,
including the name of the customer, are covered under a confidentiality
agreement.
| More... |
| 09.03.2010 | Still River Systems Selects RTI Software for Single-Room Proton Therapy System
| More... |
| 09.03.2010 | FedSources Releases "Agency Drivers" for the U.S. Department of Health & Human Services
| More... |
| 09.03.2010 | TriZetto's QuoteToCard Solution Provides Healthcare Payers with Nation's Broadest Access to Brokers Who Sell Policies and Streamlines Payers' Small Group Sales
The TriZetto Group, Inc. today announced the early availability of its
QuoteToCard solution, which offers healthcare payers end-to-end sales
automation and proprietary integration to HealthConnect, an individual
and small-group multi-payer portal with the nation's largest community
of brokers and general agents. For payers using TriZetto's QuoteToCard
solution, brokers will now be able to generate quotes, install cases,
enroll members and print identification cards either directly from the
payer's website or through an online marketplace.
| More... |
| 09.03.2010 | Idera Pharmaceuticals to Present at Roth 22nd Annual Orange County Growth Stock Conference
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company
engaged in the discovery and development of DNA- and RNA-based drug
candidates targeted to Toll-like Receptors (TLR), today announced that
it will discuss its drug discovery and development programs and provide
a general corporate overview at the Roth 22nd Annual Orange
County Growth Stock Conference on Wednesday, March 17, at 1:30 p.m. PST
(4:30 p.m. EST) at the Ritz Carlton Laguna Niguel in Dana Point, CA.
| More... |
| 09.03.2010 | Promega TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
Promega and TOP srl have combined their industry leading technologies to
provide the most sensitive tools for monitoring apoptosis in live
mammals, an important biomarker in cancer studies. Under the agreement,
the two companies are promoting the VivoGlo
Caspase 3/7 Substrate for use with transgenic repTOPTM
reporter mice. The tools allow the direct visualization and
quantification of apoptosis non-invasively in live mice.
| More... |
| 09.03.2010 | Theragenics Corporation® Announces Annual Meeting Date
Theragenics Corporation® (NYSE: TGX), a medical device
company serving the surgical products and prostate cancer treatment
markets, today announced its Annual Meeting of Stockholders will be held
on Thursday, May 13, 2010, at 9:00 a.m., Eastern Time, at The
Ritz-Carlton, Atlanta (downtown), 181 Peachtree Street, N.E., Atlanta,
GA 30303. The Board of Directors fixed the close of business on March
16, 2010, as the record date for the determination of the stockholders
entitled to notice of, and to vote at, the meeting. It is anticipated
that the Proxy Statement and Annual Report on Form 10-K will be mailed
to the stockholders entitled to notice of and to vote at the Annual
Meeting on or around April 7, 2010. The Proxy Statement and Annual
Report on Form 10-K will also be available at www.theragenics.com.
This announcement serves to satisfy the public disclosure requirement of
the Annual Meeting of the Stockholders.
| More... |
| 09.03.2010 | LYNX E/Point Achieves HFMA Peer Review Distinction
LYNX
Medical Systems, a Picis
company, announced today that Picis LYNX E/Point®
emergency department (ED) revenue management solution has achieved the
Healthcare Financial Management Association's (HFMA) prestigious Peer
Review designation following an independent board review and thorough
11-step evaluation process. This designation was earned after
demonstrating to respected members of the healthcare finance community
that E/Point meets the stringent demands of today's healthcare systems
for effectiveness, quality and ease of use, price, proven value and
superior customer and technical support.
| More... |
| 09.03.2010 | Rady Children's Hospital Selects Amcom Software for Unified Communications
Amcom
Software, Inc. today announced that it is working with Rady
Children's Hospital to implement unified communications solutions to
support information sharing throughout its facilities. The San
Diego-based hospital will leverage Amcom solutions for contact
center operations, on-call
scheduling, and staff messaging in concert with its Cisco PBX and
phones. At the heart of the project is Rady Children's goal of enhancing
the patient experience through more seamless communications among staff,
patients, and their families.
| More... |
| 09.03.2010 | Kay Bross Named Program Director, Member & Vendor Relations, SAFE-BioPharma Association
Kay Bross has been named Program Director, Member and Vendor Relations
for SAFE-BioPharma Association, the non-profit association that created
and manages the SAFE-BioPharma® digital identity and digital signature
standard for the pharmaceutical and healthcare industries.
| More... |
| 09.03.2010 | RXi Pharmaceuticals to Webcast Presentation at the ROTH 22nd Annual OC Growth Stock Conference
RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical
company pursuing the development and commercialization of proprietary
therapeutics based on RNA interference (RNAi), today announced that the
Company's President and Chief Executive Officer, Noah D. Beerman, will
present a corporate overview at the ROTH 22nd Annual OC
Growth Stock Conference on Wednesday, March 17, 2010 at 10:00 a.m. PT.
This annual three-day conference will be held March 15-17 at the Ritz
Carlton Laguna Niguel in Dana Point, CA.
| More... |
| 09.03.2010 | Trinity Health and Medicity Deploy Health Information Exchange Solution to Nearly 1,000 Physicians in 9 ½ Weeks
Medicity,
Inc. announced today that top-ranked health system Trinity
Health, comprised of 44 hospitals and numerous healthcare facilities
in eight states, went live with the first stage of its Novo
Grid deployment establishing electronic health information
exchange (HIE) with 297 affiliated physician practices and 991
physicians in three months.
| More... |
| 09.03.2010 | SMISS Launches Online Minimally Invasive Spine Programs
Since its founding in 2007, the Society for Minimally Invasive Spine
Surgery (SMISS) has become the pre-eminent professional society for MIS
surgeons. On March 1, 2010, the organization's educational activities
expanded dramatically with the launch of SMISS Highlights, an
online series of CME-accredited education modules that are free of
charge for spine surgeons.
| More... |
| 09.03.2010 | Biologics Consulting Group, Inc. Announces Stephen P. Rhodes as Senior Consultant, Expands Expertise in Medical Devices and Combination Products
Biologics Consulting Group, Inc., a regulatory affairs consulting firm,
is pleased to announce a key appointment to its highly-experienced team.
| More... |
| 09.03.2010 | InteleOne Takes Growing Radiology Business to the Next Level
Intelerad
Medical Systems, a recognized leader in medical imaging PACS and
workflow solutions, today announced that Carolina Regional Radiology PA
(CRR) will be leveraging InteleOne to interconnect its facilities. CRR
is a full-service radiology practice serving a ten-county region in
southeastern North Carolina. CRR employs 21 radiologists reporting over
half-a-million studies per year, offering on-site services and
teleradiology to two imaging centers, four hospitals, and more than a
dozen small clinics.
| More... |
| 09.03.2010 | Catalina Marketing Hires Johnson & Johnson Executive To Lead Health Care Services Division
Catalina Marketing Corporation, the global leader in precision marketing
and shopper-driven media, today announced the appointment of Renee
Selman as President of its health care division, Catalina Health
Resource, responsible for managing strategic direction, day-to-day
operations and overall unit performance.
| More... |
| 09.03.2010 | Carticept MedicalTM Announces $20 Million Series B Financing
Carticept Medical, Inc., a developer of innovative products for
the treatment of cartilage injuries and osteoarthritis, today announced
that it has completed a $20 million Series B financing round. New
investor SonoSite, Inc. joined existing investors Domain Associates and
New Enterprise Associates. The financing will provide funding for the
expected commercial launch of the Company's NavigatorTM
Delivery System, an integrated, computer-controlled, fluid delivery
system designed to automate the delivery of medication for the benefit
of both the patient and physician, as well to complete patient
enrollment in the clinical study of the Company's CartivaTM
Synthetic Cartilage Implant.
| More... |
| 09.03.2010 | FHN Hospital to Deploy ProVation® Order Sets, powered by UpToDate® Decision Support
Wolters Kluwer Health, a leading global provider of information
for healthcare professionals and students, announced today that FHN
Hospital has selected ProVation®
Order Sets, powered by UpToDate® Decision Support, to
automate the creation, deployment and maintenance of order sets.
| More... |
| 09.03.2010 | Sanofi-aventis and Merck to Create a Global Leader in Animal Health
Merck & Co., Inc. (NYSE: MRK):
| More... |
| 09.03.2010 | Quintiles erweitert Kapazitäten und Möglichkeiten zur Durchführung von Phase-I-Prüfungen
Quintiles gab heute die Eröffnung einer neuen Forschungseinrichtung in
London, Großbritannien, zur Steigerung seiner Kapazitäten für
Phase-I-Prüfungen und für mehr Möglichkeiten zur Weiterentwicklung der
translationalen Medizin bekannt.
| More... |
| 09.03.2010 | Diversey, Inc. Announces Conference Call to Review Financial Results for Fiscal Year 2009
Diversey, Inc. and Diversey Holdings, Inc. today announced that
management of both corporations will review financial results for fiscal
year ending 2009 in a combined conference call on Friday, Mar. 19, 2010
at 10 a.m. EDT. Diversey President & CEO Ed Lonergan and Chief Financial
Officer Norm Clubb will also participate in a question and answer
session.
| More... |
| 09.03.2010 | DexCom to Present at the 22nd Annual ROTH OC Growth Stock Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that Steven R. Pacelli, Chief
Administrative Officer, will present an update on DexCom at the 22nd
Annual ROTH OC Growth Stock Conference in Laguna Niguel on Monday, March
15, 2010 at 8:30 a.m. (PT). The presentation, which will occur live at
the Ritz-Carlton Hotel in Laguna Niguel, will be concurrently webcast.
The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com
under the investor relations, events and webcast section, and will be
archived for future reference.
| More... |
| 09.03.2010 | Advocates Seek Increased Federal Funding to Bridge the Gaps in Lupus Research, Awareness, and Education
On March 16, 2010, an anticipated 1,000 advocates will band together for
lupus in person and virtually by phone, email, and through social media
networks, to share their personal stories with Members of Congress
during the Lupus Foundation of America's, (LFA) Twelfth Annual Advocacy
Day.
| More... |
| 09.03.2010 | 1st Hospital in Greece Begins Certification Training to Implant SynCardia's Total Artificial Heart
On March 4 & 5, the surgical team from the Onassis Cardiac Surgery
Center, led by Dr. Petros Sfirakis, Director of the Transplantation
Department & Mechanical Support Unit and Dr. Louis Louca, Surgeon/VAD
Coordinator, completed the first phase of certification training to
implant the SynCardia
temporary CardioWest Total Artificial Heart. Team members from St.
Vincent's Hospital in Sydney, Australia, also attended the training,
including Dr. Phillip Spratt, Head of Cardiopulmonary Transplant and
Cardiothoracic Unit, Dr. Paul Jansz, Cardiothoracic and Transplant
Surgeon, Mr. Claude Soto, Clinical Perfusionist and Ms. Desiree Robson,
Cardiac Mechanical Assist Co-ordinator.
| More... |
| 09.03.2010 | New Data Presented at American Burn Association's Annual Meeting Support Safety Profile of RECOTHROM® Thrombin, Topical (Recombinant) in Pediatric Patients
ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of
safety and immunogenicity data among pediatric burn patients at the 42nd
Annual Meeting of the American Burn Association in Boston, MA. The study
marks the first dedicated look at the safety and immunogenicity of any
stand-alone thrombin in pediatric surgical patients. The investigators
concluded that RECOTHROM did not appear to be associated with any
treatment-related adverse events when used as an aid to hemostasis in
pediatric patients undergoing synchronous burn wound excision and skin
grafting. Additionally, none of the pediatric burn patients who were
administered RECOTHROM during their surgical procedure developed
product-specific antibodies through post-operative (post-op) day 29.
| More... |
| 09.03.2010 | MagnaCare Positioned for Growth in National Health Care Marketplace, Expanding Member-Centric Programs and Services Built on Customer Satisfaction
MagnaCare, (www.magnacare.com)
a health plan services company with national reach, today announces
plans to build on its stable customer base and dominant position in the
fiercely competitive NY/NJ/CT region to expand into the broader health
care services market. Pointing to innovative differentiators fueling
continued growth and expanded market share, MagnaCare cites its ability
to provide exemplary customer service and offer deep discounts to
Taft-Hartley funds, self-insured companies, commercial insurers for
health, workers' compensation, or no fault, Third Party Administrators
(TPAs), and government entities.
| More... |
| 09.03.2010 | Research and Markets: In 2013, the Global Oral Hygiene Market Is Forecast To Have a Volume of 14.3 Billion Units, an Increase Of 12.8% Since 2008
| More... |
| 09.03.2010 | Pharmadule AB: Pharmadule Receives an Order From Sicor Biotech UAB In Lithuania for a Complete Biotech Production Facility
Pharmadule AB, the world leader in high-tech modular facilities for the
pharmaceutical and biopharmaceutical industries, has signed a contract
with Sicor Biotech UAB in Vilnius, Lithuania for the delivery of a
modular production facility. Pharmadule's scope comprises design,
fabrication, installation and validation of a complete Biotech
Production Facility. Pharmadule's modular concept allows 80% of the
construction to be completed in Pharmadule's workshop resulting in a
very high and predictable quality, a short delivery schedule and
financial benefits for the customers.
| More... |
| 09.03.2010 | Positron Corporation Cites JACR Study That Reports a 737% Growth Rate in PET among 5 Speciality Groups Including Cardiology
Positron Corporation (OTCBB:POSC). The growth rate among nonradiologists
who own or lease PET
equipment was far higher than radiologists between 2002 and 2007,
according to a study published in the March issue of the Journal of
the American College of Radiology (JACR
Volume
7, Issue 3, March 2010, Pages 187-191).
| More... |
| 09.03.2010 | Research and Markets: An Essential Report on the Pharmaceutical Industry in Botswana
| More... |
| 09.03.2010 | Research and Markets: Systemic Fungal Infection Therapeutics Market - South Korea
| More... |
| 09.03.2010 | ACM Global Central Lab Appoints General Manager of Asia Pacific as Global Footprint Expands
ACM
Global Central Laboratory, the global central lab that continually
defines the customer-service standard with its flexible approach, today
announced the newest member of its Clinical Trials team, Nandan Rao as
the general manager, Asia Pacific located in Mumbai, India. Initially,
Rao will have oversight of trials conducted with ACM Global's partner
lab in the region. He will also be building the ACM Global
infrastructure and team throughout Asia Pacific, as a result of
increased demand.
| More... |
| 09.03.2010 | Research and Markets: China Veterinary Pharmaceutical Manufacturing Industry, 2010
| More... |
| 09.03.2010 | KBR Subsidiary Awarded Contract for Piedmont Newnan Hospital Replacement Facility
KBR (NYSE: KBR) announced that its Building Group has been awarded a $94
million contract by Piedmont Healthcare to provide preconstruction and
construction services for a replacement facility for Piedmont Newnan
Hospital in Newnan, Georgia. When complete, the new hospital is expected
to be the tallest building in the southwest metropolitan Atlanta area.
The Building Group's Nashville and Atlanta offices are responsible for
this significant healthcare construction project, which represents the
first phase of a long-term building program planned for this campus.
| More... |
| 09.03.2010 | ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2009
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company
utilizing innovative technology to fuel drug discovery and clinical
development of novel treatments for central nervous system disorders,
today reported its financial results for the fourth quarter and year
ended December 31, 2009.
| More... |
| 09.03.2010 | Susan G. Komen for the Cure® Honored as Most Valued Non-Profit Brand, Top Ranked for Trust, Charity People Are Most Likely to Donate To
Top rankings for brand value, trust, and the charity
people are most likely to donate to, affirm the strength of the
28-year promise of Susan G. Komen for the Cure®: the world's largest
breast cancer organization: to save lives and end breast cancer forever.
| More... |
| 09.03.2010 | ZenBio Licenses an Important Cell Line from Harvard to Drive Metabolic Disease Research
ZenBio announce that they will be a commercial source for the popular
murine 3T3-L1 cell line, which has been fundamental in metabolic disease
research for 30 years. Originally derived from Swiss mouse embryo tissue
by Dr. Howard Green of the Department of Cell Biology at Harvard Medical
School, the 3T3-L1 system has been pivotal in advancing the
understanding of basic cellular mechanisms associated with diabetes,
obesity and other related disorders.
| More... |
| 09.03.2010 | NexMed to Present at the Roth 22nd Annual OC Growth Stock Conference
NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products
based on the NexACT® technology, announced today that Bassam Damaj,
Ph.D., President and Chief Executive Officer, will present an overview
of the Company at 1:00 p.m. Pacific Time on Wednesday, March 17, 2010 at
the Roth 22nd Annual OC Growth Stock Conference.
| More... |
| 09.03.2010 | Angeion Corporation Names Scott Shuda to Board of Directors
Angeion Corporation (NASDAQ: ANGN) today announced that Scott Shuda has
been named to the company's board of directors.
| More... |
| 09.03.2010 | Rush University Medical Center to Pay $1.6 Million to Resolve False Claims Act Allegations
Goldberg Kohn proudly represents Dr. Robert Goldberg and June Beecham in
their lawsuit against Rush University Medical Center, Midwest
Orthopedics, LLC, Rush Surgicenter, Ltd. and Brian Cole, MD.
| More... |
| 09.03.2010 | NMT Medical to Release Fourth-Quarter and Year-End 2009 Financial Results on March 25
NMT
Medical, Inc. (NASDAQ: NMTI) today announced that it will release
its fourth-quarter and year-end 2009 financial results before the market
opens on Thursday, March 25, 2010.
| More... |
| 09.03.2010 | Hercules Technology Growth Capital Provides an Additional $3.0 Million of Capital to InfoLogix, Inc. to Launch New Products Roll-Out and Fund New Growth
Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the leading
specialty finance company providing venture debt and equity to venture
capital and private equity-backed technology and life science companies
at all stages of development, today announced that it has increased its
commitment to grow the operations of InfoLogix, Inc. (NASDAQ:IFLG), a
leading technology provider of enterprise mobility solutions for the
healthcare and commercial industries. Hercules invested an additional
$3.0 million of capital to fund the launch of two new strategic product
offerings with high growth potential.
| More... |
| 09.03.2010 | Presentation by Lowell Parsons, MD Now on Urigen.com
Urigen Pharmaceuticals, Inc. (OTCBB:URGP), a specialty pharmaceutical
company focused on the development of treatments for urological
disorders and pain, announced today that video of the recent
presentation made by Prof. Lowell Parsons in Atlanta on February 25th,
2010 is now available at www.urigen.com.
| More... |
| 09.03.2010 | Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year Financial Results for the Period Ended December 31, 2009
Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of
products designed to protect people, products and environments,
including disposable protective apparel, and building products, today
announced record financial results for the fourth quarter and the
full year ended December 31, 2009.
| More... |
| 09.03.2010 | Condoms in Porn: AHF Reports Effort Gains Traction as Cal/OSHA Recommends Advisory Panel on Adult Film Worker Safety
In response to a petition seeking to amend state health regulations to
better protect workers in the adult film industry that was filed in
December by AIDS
Healthcare Foundation (AHF), California's Department Occupational
Safety and Health (Cal OSHA) is recommending that an advisory panel
be convened to determine whether—and how—to amend state health statutes
to better protect such film workers.
| More... |
| 09.03.2010 | CoActiv Announces EXAM-PACS®-ORTHO for iPad at AAOS
In the forefront of breaking technology, CoActiv Medical (Booth 635)
announces at the American Academy of Orthopaedic Surgeons (AAOS)
conference new EXAM-PACS touch screen image viewing for the recently
announced Apple iPad large-screen digital viewing and communications
device. Based on the existing EXAM-PACS iPhone image viewing system
incorporated in its orthopedic and other PACS solutions, the new iPad
system will support bi-directional data communication between a PACS and
any iPad using the new device's built-in WiFi capabilities. This version
of EXAM-PACS for iPad will also be fully compatible with the Apple iPad
3G model scheduled for release in April. The updated 3G model will allow
connectivity for anywhere, anytime image viewing.
| More... |
| 09.03.2010 | South Carolina Kidney Patients to Re-Visit State Capitol, Urging Legislators to Make Medigap Secondary Insurance Accessible to All
Dialysis patients, family members and kidney care advocates from across
South Carolina will travel to the State House tomorrow to urge state
Senators to support Medigap legislation S. 1128, sponsored by Senators
Harvey Peeler (R-Cherokee) and Phillip Shoopman (R-Greenville). South
Carolina kidney patients are joined in advocating for this legislation
by the National Kidney Foundation Serving the Carolinas, South Carolina
Region (NKF) and Dialysis Patient Citizens (DPC). If enacted, the bill
will help approximately 500 South Carolinians suffering from kidney
failure and patients deemed disabled who are having difficulty accessing
private market health insurance coverage for necessary medical care.
| More... |
| 09.03.2010 | Fitch: Ascension Health Credit Group (MI) Revs' Ratings Unaffected by Remarketing
According to Fitch Ratings, the remarketing of Michigan State Hospital
Finance Authority (MI) (Ascension Health Credit Group) variable rate
revenue bonds series 1999B-1 does not affect the bonds' current ratings.
| More... |
| 09.03.2010 | IntriCon Reports 2009 Fourth-Quarter and Full-Year Results
IntriCon Corporation (NASDAQ: IIN), a designer, developer,
manufacturer and distributor of body-worn medical and electronics
devices, today announced financial results for its 2009 fourth quarter
and full year ended December 31, 2009.
| More... |
| 09.03.2010 | InSite Vision Reports Full Year and Fourth Quarter 2009 Financial Results
InSite Vision Incorporated (OTCBB: INSV) today reported financial
results for the full year and fourth quarter ended December 31, 2009.
| More... |
| 09.03.2010 | Part Two of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com
| More... |
| 09.03.2010 | DexCom Inc. Reports Fourth Quarter and Full Year 2009 Financial Results
DexCom, Inc. (Nasdaq:DXCM) today reported its audited financial results
as of and for the quarter and fiscal year ended December 31, 2009.
| More... |
| 09.03.2010 | Salix Pharmaceuticals Reports 4Q2009 and FY2009 Results
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and
operating results for the fourth quarter and full year ended December
31, 2009.
| More... |
| 09.03.2010 | Catholic Charities Launches Transformational Catholic Emerging Leaders (CEL) Program
Catholic Charities Health and Human Services (Catholic Charities) has
introduced a transformational leadership development program called
Catholic Emerging Leaders (CEL). The CEL Program helps emerging leaders
develop their leadership skills, knowledge and exposure. The goals of
the program are to:
| More... |
| 09.03.2010 | Glasgow Health Solutions Ltd: Conference Offers Hope for People with MS.
People with MS (Multiple Sclerosis) and others suffering with a range of
often debilitating inflammatory conditions such as Chronic Fatigue
Syndrome and Fibromyalgia, will take heart from advances in treatment
for their conditions, and will follow events at The 2nd European LDN
Conference with interest.
| More... |
| 09.03.2010 | The Right to Remain Frozen: HRO Win Upholds Woman's Desire for Cryonic Preservation
In one of the more unusual cases to confront the Colorado courts, the El
Paso County Probate Court in Colorado Springs has granted Holme Roberts
& Owen (HRO) client Alcor Life Extension Foundation of Scottsdale,
Arizona, custody of the remains of Colorado Springs nurse Mary Robbins.
The ruling upheld Ms. Robbins's 2006 agreement with Alcor to have her
head cryonically preserved after death, hoping that future technologies
could bring her back to life.
| More... |
| 09.03.2010 | ACIST Medical Systems and HealthTrust Purchasing Group Enter Three-Year Contract
ACIST Medical Systems, Inc., a world-leading provider of
contrast-delivery systems for cardiology and radiology imaging,
announced today that HealthTrust Purchasing Group, LP (HealthTrust),
Brentwood, Tenn., one of the leading health care group purchasing
organizations, has awarded the company a three-year contract, effective
December 1, 2009, for ACIST cardiovascular injection technology, the
ACIST | CVi® Contrast Delivery System.
| More... |
| 08.03.2010 | Inhibitex to Present at Two Upcoming Conferences
Inhibitex, Inc. (Nasdaq: INHX), today announced that Russell H. Plumb,
President and Chief Executive Officer, is scheduled to present an
overview of the company and its pipeline of differentiated antiviral
compounds at the following two conferences:
| More... |
| 08.03.2010 | Investigation Relating to the Labeling of Sunsweet Antioxidant Blend Dried Fruit Mixes Announced by Stember Feinstein Doyle & Payne, LLC
The law firm of Stember Feinstein Doyle & Payne, LLC is investigating
possible claims related to the labeling of Sunsweet Antioxidant Blend
Dried Fruit Mixes, which is manufactured by Sunsweet Growers, Inc..
| More... |
| 08.03.2010 | ADAO Praises U.S. House of Representatives for Introduction of HR 1138 that Establishes "National Asbestos Awareness Week"
The Asbestos
Disease Awareness Organization (ADAO), the leading organization
serving as the voice of asbestos victims, today applauds Representative
Steve Cohen (D-TN - 09) and cosponsors for introducing a resolution that
declares the first week of April as "National Asbestos Awareness Week"
and seeks to "raise public awareness about the prevalence of
asbestos-related diseases and the dangers of asbestos exposure."
| More... |
| 08.03.2010 | TriTech Software Systems Completes Acquisition of Ortivus North America and Introduces New Company Name - TriTech Emergency Medical Systems
TriTech Software Systems, a leading provider of public safety and
pre-hospital care software solutions, announces today it received
approval from Ortivus AB and TriTech shareholders to complete the
acquisition of Ortivus North America. In conjunction with the
acquisition, Ortivus North America will be renamed TriTech Emergency
Medical Systems.
| More... |
| 08.03.2010 | Fitch Upgrades Valley View Regional Hospital, Oklahoma's Revs to 'BBB+'
Fitch Ratings takes the following rating action on Valley View Regional
Hospital, Oklahoma as part of its continuous surveillance effort:
| More... |
| 08.03.2010 | Publix Issues Voluntary Recall on Four Seasoning Mixes
Publix Super Markets is issuing a voluntary recall for four (4)
varieties of seasoning mixes. The products have been manufactured with
HVP (hydrolyzed vegetable protein) supplied by Basic Food Flavors of Las
Vegas, Nevada. The HVP may be contaminated with Salmonella. Consumption
of products containing Salmonella can cause serious and sometimes fatal
infections in young children, frail or elderly persons and others with
weakened immune systems. The recalled products include all lot codes for
the following items:
| More... |
| 08.03.2010 | Golf Trust Stockholders Approve Pernix Merger
Golf Trust of America, Inc. ("GTA") (NYSE Amex: GTA) announced that
GTA's stockholders voted to approve the four proposals that were
conditions to closing the previously-announced merger between GTA and
Pernix Therapeutics, Inc. ("Pernix") at a Special Meeting of
Stockholders held earlier today. Holders of approximately 78.2% of Golf
Trust outstanding common shares voted in favor of the proposal to issue
the merger shares, or 99.2% of total shares voted. The combined company
will be renamed Pernix Therapeutics Holdings, Inc. We currently
anticipate the merger will close on March 9, 2010 and that trading will
commence on the NYSE Amex under the symbol "PTX" on March 10, 2010.
| More... |
| 08.03.2010 | ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU COMP
ImmunoGen,
Inc. (Nasdaq: IMGN), a
biotechnology company that develops targeted anticancer products using
its antibody expertise and Targeted Antibody Payload (TAP) technology,
today announced that the US Food and Drug Administration (FDA) has
granted orphan drug designation to its IMGN901 compound when used for
the treatment of Merkel cell carcinoma (MCC). Through a separate
process, the European Union (EU) Committee for Orphan Medicinal Products
(COMP) concurrently also granted IMGN901 orphan medicinal product
designation for the treatment of MCC.
| More... |
| 08.03.2010 | MedAssets Engages KPMG as Auditor
MedAssets, Inc. (NASDAQ: MDAS) today announced its Board of
Directors has selected KPMG LLP to serve as the Company's independent
registered public accounting firm for the fiscal year ending December
31, 2010. KPMG replaces the Company's previous independent registered
accountants, BDO Seidman, LLP which served as the Company's public
accounting firm since 2004.
| More... |
| 08.03.2010 | Apolo Anton Ohno Visits El Rodeo Middle School to Promote The Century Council's Ask, Listen, Learn Program
The most decorated U.S. Winter Olympian in history and star of the 2010
Winter Olympic Games, Apolo
Anton Ohno has partnered with The
Century Council and its Ask,
Listen, Learn: Kids
and Alcohol Don't Mix program. Today in California, Ohno,
in conjunction with the newly formed Apolo Anton Ohno Foundation, began
a five-city tour to schools throughout the U.S. encouraging kids to say
"YES" to a healthy lifestyle and "NO" to underage drinking. The Apolo
Anton Ohno Foundation, established by the eight-time Olympic medalist,
will focus on providing youth of all ages and socio-economic backgrounds
with the opportunity to play sports, be active and learn about the
benefits of making responsible and positive choices.
| More... |
| 08.03.2010 | Herbalife Family Foundation Expands Casa Herbalife Programs in Mexico
The Herbalife Family Foundation (HFF) announced the opening of two
additional Casa Herbalife programs in Mexico, in Tijuana, Baja
California and Celaya, Guanajuato.
| More... |
| 08.03.2010 | Month-Long Spotlight on Alzheimer's Disease in Rockefeller Center
Throughout the month of March, visitors to Rockefeller Center in the
heart of midtown Manhattan will get an unexpected lesson on Alzheimer's
disease.
| More... |
| 08.03.2010 | Flamel Technologies Announces Fourth Quarter and Year-End 2009 Results
Flamel Technologies (NASDAQ:FLML) today announced its financial
results for the fourth quarter and year ended December 31, 2009.
| More... |
| 08.03.2010 | BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11
BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) today announced that the
Company plans to release its financial results for the three and twelve
months ended December 31, 2009, on Thursday, March 11, 2010 after the
close of market. The Company will host a conference call and audio
webcast to discuss its fourth quarter and year-end financial results,
product development programs and business activities at 8:30 a.m. EST
Friday, March, 12, 2010.
| More... |
| 08.03.2010 | Natrol Launches New Superfruit Antioxidant Supplements to Support Health and Wellness: Natrol® MaquiBerry, Natrol® Resveratrol Diet, and Natrol® Resveratrol Weekend Cleanse?
Natrol,
Inc., a premier marketer, manufacturer, and distributor of
nationally branded nutritional products, introduces three new
nutritional supplements -- Natrol®
MaquiBerry, Natrol®
Resveratrol Diet, and Natrol®
Resveratrol Weekend Cleanse -- with superfruit
antioxidant
capacity. These three new products join Natrol's popular line of açaí
superfruit offerings -- including Natrol®
AçaíBerry 1,000 mg, Natrol®
AçaíBerry Diet, and, Natrol®
AçaíBerry Weekend Cleanse -- making Natrol the #1 Acai
supplement brand at U.S. grocery stores, drug stores, and mass
merchandise retailers.
| More... |
| 08.03.2010 | Investigation Relating to the Labeling of Nestle Juicy Juice Announced by Stember Feinstein Doyle & Payne, LLC
The law firm of Stember Feinstein Doyle & Payne, LLC is investigating
possible claims related to the labeling of Nestle Juicy Juice.
| More... |
| 08.03.2010 | Exelixis Announces Restructuring
Exelixis, Inc. (Nasdaq:EXEL) today announced a restructuring as a
consequence of its continued strategy to focus resources on the
development of its key late-stage compounds. As its first priority, the
company will aggressively advance XL184, XL147 and XL765, each of which
is the subject of a large clinical development program. Additionally,
Exelixis retains a fully integrated R&D organization, and will continue
to advance new compounds into development, although the number will be
reduced for the foreseeable future. Exelixis has retained the ability to
meet all of its obligations to existing partners. Further, as a result
of its retained R&D capabilities and its numerous unpartnered clinical
and preclinical compounds, the company expects that its ongoing and
future business development discussions will be unaffected.
| More... |
| 08.03.2010 | Orthofix International Sells Vascular Business to Covidien
Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today
it has sold the assets of its vascular business, including its AV-Impulse®
mechanical compression technology, to Covidien.
| More... |
| 08.03.2010 | Advaxis Confirms Long-Term Stability of Listeria-Based Immunotherapeutics' Formulations
Advaxis,
Inc., (OTCBB: ADXS), the live, attenuated Listeria
monocytogenes (Listeria) immunotherapy company, has confirmed
the long-term stability of its first clinical formulation of ADXS11-001,
the Company's lead immunotherapeutic.
| More... |
| 08.03.2010 | CORRECTING and REPLACING The Coca-Cola System Delivers on its Commitment to Schools Across the U.S.
Second graph, first sentence of release should read: "It was the right
thing to do in 2006, and it continues to be the right thing to do
today," said Sandy Douglas, president of Coca-Cola North America (sted
"It was the right thing to do in 2006, and it continues to be the right
thing to do today," said Sandy Douglas, president of Coca-Coca North
America).
| More... |
| 08.03.2010 | Michael A. Rashid, President and CEO, AmeriHealth Mercy Family of Companies, Appoints Joyce S. Hagen as Chief Marketing and Development Officer
Michael A. Rashid, President and CEO of the AmeriHealth Mercy Family of
Companies, the largest organization of Medicaid managed care plans and
related businesses in the United States, announced today that Joyce S.
Hagen has been appointed Chief Marketing and Development Officer of the
company, effective immediately.
| More... |
| 08.03.2010 | Institute for Systems Biology Receives $6 Million Gift from Anonymous California Donor
The Institute for Systems Biology, an independent, non-profit
biomolecular research institute, has received a $6 million gift from a
California venture capitalist and philanthropist to support strategic
organizational objectives.
| More... |
| 08.03.2010 | XenaCare Holdings Announces Changes to Cobroxin Advertising Campaign and Signing of Professional Athletic Sponsorship
XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the
marketing and retail distribution of consumer healthcare products, has
announced today that it will be replacing advertisements scheduled to
appear in the National Collegiate Athletic Association (NCAA) March
Madness Tournament program and Final Four Game program with
advertisements in Major League Baseball (MLB) yearbooks. The change in
advertising occurred due to unforeseen timing circumstances with
Professional Sports Publications, the publisher of the NCAA gameday
programs.
| More... |
| 08.03.2010 | Greyson International, Inc. ShopNBC Appearance Time Change: Greyson to Now Appear in Prime Time on Wednesday, March 10, at 7 p.m. EST
Greyson International, Inc. (GYSN.PK) announced today its upcoming
ShopNBC appearance has been moved to prime time. Veteran television
personality and Greyson International CEO Harvey Tauman will appear as
the spokesperson on behalf of the Company to feature the Company's new
Trilexon® products on air on Wednesday, March 10, 2010 at approximately
7 p.m. EST during the "ShopBeauty" hour.
| More... |
| 08.03.2010 | Susan G. Komen for the Cure® Honored as Most Valued Non-Profit Brand, Top Ranked for Trust, Charity People Are Most Likely to Donate To
Top rankings for brand value, trust, and the charity
people are most likely to donate to, affirm the strength of the
28-year promise of Susan G. Komen for the Cure®: the world's largest
breast cancer organization: to save lives and end breast cancer forever.
| More... |
| 08.03.2010 | Research and Markets: An Essential Report on the Global Biotechnology (Pharmaceuticals)
| More... |
| 08.03.2010 | Synovis Life Technologies Announces New Share Repurchase Program
Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial
and surgical products company, today announced that its board of
directors has approved a program for the company to repurchase up to 1
million shares of its common stock, in addition to the approximately
66,000 shares remaining to be purchased under an existing share
repurchase program approved by the board in September 2009. Synovis
plans to make purchases in either the open market or through private
transactions from time to time, in accordance with Securities and
Exchange Commission regulations. The timing and extent to which the
company buys back shares will depend on market conditions and other
corporate considerations. The repurchase program does not have an
expiration date. As of Jan. 31, 2010, the company had $56.5 million in
cash, cash equivalents and investments. This represents the third stock
buyback Synovis has announced in less than two years.
| More... |
| 08.03.2010 | Skilled Nursing Prices Rise, Assisted Living Prices Fall in 2009 According to New Report from Irving Levin Associates, Inc.
After dropping 17% in 2008 from an all-time high set in 2007, the
average price paid per bed for skilled nursing facilities increased
slightly in 2009, according to a new report on the seniors housing and
care M&A market to be published by Irving Levin Associates, Inc., a
research and publishing firm that tracks mergers and acquisitions in the
seniors housing and health care markets. The skilled nursing industry
has been resilient in the recent economic downturn, and despite
uncertainty with regard to Medicaid and Medicare reimbursement, buyers
were still finding opportunities in a relatively slow acquisition
market. In the 2006 to 2007 period, prices were pushed up as Medicare
and its higher rates became a more important part of the skilled nursing
business, drawing more investors into the market. With the credit crunch
and market uncertainty, this started to unravel, but not nearly to the
extent as in other real estate-oriented sectors.
| More... |
| 08.03.2010 | Crimson President to Address International Compliance Conference
Crimson Life Sciences, the specialized medical device division of global
language and business services leader TransPerfect, today announced that
the company's president, Marc H. Miller, will present at a full-day
industry conference hosted by the New England Biomedical Division of the
American Society for Quality (ASQ). The conference, titled
"International Compliance: Supporting Global Medical Device Marketing
Initiatives beyond the US, Canada & Europe," will take place on
Thursday, March 11, at the Waltham Woods Conference Center—agenda and
registration information can be found here.
| More... |
| 08.03.2010 | The Coca-Cola System Delivers on its Commitment to Schools Across the U.S.
Today, the Coca-Cola system in the U.S. proudly joined with the William
J. Clinton Foundation, the Alliance for a Healthier Generation and
members of the American Beverage Association (ABA) to announce that it
has successfully delivered on its three-year commitment to increase the
availability of no- and low-calorie beverages to schools across the
country. As a result, the industry has driven an 88 percent reduction in
total calories from beverages delivered to schools in the first half of
the current school year, as compared to the first of the 2004-2005
school year.
| More... |
| 08.03.2010 | Jay Feldstein, DO, Named Interim Regional President of the Northeast Region and Corporate Chief Medical Officer of AmeriHealth Mercy
The AmeriHealth Mercy Family of Companies today announced that Jay
Feldstein, DO, has been named Interim Regional President of the
Northeast Region and Corporate Chief Medical Officer.
| More... |
| 08.03.2010 | Nuvilex, Inc. Executes Letter of Intent to Pursue Merger with the Energy Innovation Group, LLC
Nuvilex, Inc. (OTC Bulletin Board: NVLX) announces today that it has
entered into a letter of intent granting Nuvilex, Inc. an exclusive
sixty-day right to define and structure a merger with the Energy
Innovation Group, LLC (EIG) on mutually acceptable terms and conditions.
EIG's mission is to bring a broad array of technology, inclusive of the
latest advances in traditional and emerging technologies and incentive
opportunities to the commercial and public sector marketplace to reduce
energy consumption. Established in 2000 by Mr. Sidney Pelston, EIG is
the developer of the Energy Grand Buffet, which has integrated all the
critical elements for the commercialization of energy efficiency. EIG is
a privately held and profitable company. Nuvilex is working with Mr.
Victor Caron of Ideal Corporate Funding to assist the Company in its
pursuit of EIG.
| More... |
| 08.03.2010 | WhiteGlove Secures Funding for National Expansion
WhiteGlove House Call Health, Inc. (www.whiteglove.com),
a new provider choice in medical care that offers affordable,
high-quality routine care at the home or work, announced today that it
has closed a series C round of funding to start expanding outside of
Texas.
| More... |
| 08.03.2010 | Research and Markets: An Essential Report on the Biotechnology Sector
| More... |
| 08.03.2010 | Flogging Molly's New Video and PSA for "Punch Drunk Grinning Soul"
"Now this punch drunk grinning soul, in its corner begs no more." Lyrics
made more haunting by Flogging Molly's new music video for their single,
"Punch Drunk Grinning Soul." Originally penned as an allegorical
biography about a young man who unexpectedly committed suicide, the
video takes the theme one step further and applies it to a malady faced
by millions of people the world over post traumatic stress disorder or
PTSD. The video begins with a public service announcement for PTSD
narrated by singer Dave King and Mike Regan, a distinguished Vietnam war
veteran and the father of the band's fiddle player, Bridget Regan.
| More... |
| 08.03.2010 | Anne Morrissey Named Executive Vice President and Chief Operating Officer of AmeriHealth Mercy Family of Companies
Michael A. Rashid, President and Chief Executive Officer of the
AmeriHealth Mercy Family of Companies, today announced that Anne
Morrissey has been named Executive Vice President and Chief Operating
Officer of the company. AmeriHealth Mercy is the largest organization of
Medicaid managed care plans and related businesses in the United States,
touching the lives of more than 6.5 million members.
| More... |
| 08.03.2010 | Research and Markets: An Essential Report on the Global Generic Pharmaceuticals Industry
| More... |
| 08.03.2010 | 10 Small Businesses Awarded Scholarships to Attend International Biotechnology Convention, Other Funds Still Available
Ten Wisconsin biotechnology companies have been awarded scholarships of
$1,100 each to support them in attending the Biotechnology Industry
Organization's (BIO) International Convention at Chicago's McCormick
Place May 3-6, 2010 in Chicago. All recipients plan to participate in
BIO's one-on-one partnering with potential customers from around the
world, or to present to potential investors.
| More... |
| 08.03.2010 | Virtual Radiologic Wins Stevie® Award for Technology-Enabled Customer Service
Virtual Radiologic Corporation (NASDAQ:VRAD), a national radiology
practice, has been awarded the Stevie® Award for Best Use of Technology
in Customer Service in the fourth annual Stevie Awards for sales and
customer service.
| More... |
| 08.03.2010 | Media & Internet Companies Get Spotlight at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010
ROTH Capital Partners (ROTH), www.roth.com,
a full service investment bank recognized for providing financing and
advisory services to emerging growth companies worldwide, today
announced that the upcoming 22nd Annual OC Growth Stock Conference will
feature a Media and Internet Track with presentations from leading
companies in advertising, entertainment, content distribution and
exhibition, media technology, and e-commerce. The invitation-only
conference will be held March 15-17, 2010 at The Ritz Carlton, located
at 1 Ritz Carlton Drive, Dana Point, California.
| More... |
| 08.03.2010 | PharPoint Research Incorporates Medrio EDC Software into its Data Management Offerings
PharPoint Research, Inc., a drug development service company providing
biostatistics and data management services to the pharmaceutical and
biotechnology industries, announces that it has incorporated Medrio's
EDC technology platform into its growing suite of data management
applications.
| More... |
| 08.03.2010 | Implantable Provider Group Announces Investment from Sequoia Capital
Implantable Provider Group (IPG), a leading provider of implantable
device management, announced today that it has secured an investment
from Sequoia Capital. The funding will enable IPG to invest in future
growth initiatives.
| More... |
| 08.03.2010 | Exactech to Meet with Financial Analysts at AAOS Orthopaedic Meeting; Present Growth Strategies at Investor Conference
Exactech,
Inc. (Nasdaq: EXAC), a developer and producer of bone and joint
restoration products for hip, knee, shoulder, spine and biologic
materials, today announced its schedule of upcoming investor events.
| More... |
| 08.03.2010 | Millennium Announces First Clinical Data For TAK-700 Prostate Molecule at ASCO GU
Millennium:
The Takeda Oncology Company today announced the presentation of
safety, pharmacokinetic and efficacy data from the Phase I portion of a
Phase I/II clinical trial evaluating TAK-700 in patients with metastatic
castration resistant prostate cancer (mCRPC). These data were presented
at the American Society of Clinical Oncology Genitourinary Cancers
Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA.
| More... |
| 08.03.2010 | Leading Clinical Expert Joins AirStrip Technologies
Nancy Hudecek, RN, BSN, MS, has joined AirStrip TechnologiesTM
as the Vice President of Clinical Excellence and Risk Management,
AirStrip officials announced today.
| More... |
| 08.03.2010 | X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology
X-spine Systems, Inc., a global manufacturer of implants and instruments
for spinal surgery, announced today that it has entered into an
exclusive license agreement with Gamma Spine for the development and
distribution of its minimally invasive spinal fixation technology. Gamma
Spine, founded by Dr. Vijay Goel, Ph.D., will participate in the
development process with X-spine. "I am thrilled be working with Dr.
Goel, who is one of the world's most renowned and published experts in
spinal biomechanics, to develop this unique and valuable technology,"
stated Dr. David Kirschman, President and CEO of X-spine. The
patent-pending device allows for the fixation of adjacent vertebral
segments with minimal tissue disruption while attaining the
biomechanical advantages of a traditional full-exposure system.
| More... |
| 08.03.2010 | P.F. Chang's China Bistro Launches Expanded Gluten Free Menu
P.F. Chang's China Bistro (NASDAQ: PFCB) announced today a newly
expanded Gluten Free Menu, featuring beef entrees for the first time.
Gluten intolerant diners can now enjoy a wider range of dining options,
from P.F. Chang's signature Chicken Lettuce Wraps and Mongolian Beef to
a Flourless Chocolate Dome for dessert.
| More... |
| 08.03.2010 | Bristol-Myers Squibb to Present at Cowen and Company Health Care Conference
Bristol-Myers
Squibb Company (NYSE:BMY) will present at the 30th Cowen
and Company Health Care Conference on Tuesday, March 9, 2010 in Boston. Lamberto
Andreotti, president, chief operating officer and CEO-designate,
Bristol-Myers Squibb, will make a formal presentation about the company
at 1:30 p.m. ET on March 9.
| More... |
| 08.03.2010 | Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company," Pink
Sheets: TAROF) today reported that it received approval from the U.S.
Food and Drug Administration for its Abbreviated New Drug Application
("ANDA") for Fluorouracil Topical Cream USP, 5% ("fluorouracil cream").
| More... |
| 08.03.2010 | Bridgewell Resources Launched with Acquisition of Assets From North Pacific Group
Atlas Holdings LLC ("Atlas") has acquired certain assets of Portland,
Oregon based North Pacific Group, Inc. ("NPG") related to NPG's utility
and construction, food and agriculture, and hardwood and industrial
products divisions. The assets were acquired by an Atlas affiliated
entity, Bridgewell Resources LLC ("Bridgewell Resources" or
"Bridgewell").
| More... |
| 08.03.2010 | Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical
company focusing on the clinical development of new dyslipidemia
therapies, today announced commencement of operations in Bedminster, New
Jersey. Omthera's lead product candidate, Epanova, an Omega 3 fatty
acid containing a novel formulation of eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), has shown promising results in lowering
triglycerides in earlier clinical trials, as well as an excellent safety
and tolerability profile. The Omthera management team includes drug
development and commercialization expert Jerry Wisler, president and
chief executive officer, and cardiologist and clinical expert Michael
Davidson, M.D., chief medical officer.
| More... |
| 08.03.2010 | Starkey Announces Exclusive Licensing Agreement with Nickelodeon & Viacom Consumer Products to Create Pediatric Hearing Aids
Starkey
Laboratories, Inc., one of the world's leading hearing
technology companies, is excited to announce an exclusive licensing
agreement with Nickelodeon & Viacom Consumer Products (NVCP) to launch
co-branded pediatric hearing aids. The pediatric earmolds specifically
created for children ages 0-13 will feature characters from
Nickelodeon's most popular TV shows, including SpongeBob SquarePants,
iCarly, Go, Diego, Go! and Dora the Explorer.
| More... |
| 08.03.2010 | American CareSource Names Matthew D. Thompson as Interim Chief Financial Officer
American CareSource Holdings (NASDAQ: ANCI) announced today that Matthew
D. Thompson, Vice President, Finance, has been named Interim Chief
Financial Officer. Thompson replaces Steven J. Armond, whose employment
with American CareSource Holdings has ended effective immediately.
| More... |
| 08.03.2010 | CardiacAssist will host TandemHeart® 2000th Case Symposium and exhibit at American College of Cardiology annual meeting
CardiacAssist
Inc. announced today that it will exhibit
its TandemHeart®
System (Booth 356) in Atlanta at the American College of
Cardiology (ACC) 59th Annual Scientific Session that begins on Sunday,
March 14th, at the Georgia World Congress Center.
| More... |
| 08.03.2010 | Celldex Therapeutics to Present at the Cowen & Company 30th Annual Health Care Conference
Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony
S. Marucci, President and Chief Executive Officer of Celldex
Therapeutics, Inc., will present at the 30th Annual Cowen &
Company Health Care Conference at the Boston Marriott Copley Place on
Wednesday, March 10, 2010 at 11:00 a.m. Eastern Time.
| More... |
| 08.03.2010 | Harvard University and Dana-Farber Cancer Institute Grant Acetylon Exclusive License to Breakthrough Discovery Platform for Next Generation HDAC Inhibitors
Harvard University and Dana-Farber Cancer Institute announced today that
they have concluded a major licensing agreement with Acetylon under
which Harvard and Dana-Farber granted an exclusive therapeutic license
to a robust platform technology and chemical methodology that enables
high-throughput screening and lead optimization for HDAC inhibitor
compounds. Under terms of the Agreement, Harvard and Dana-Farber
received equity from Acetylon, and will receive downstream royalty and
milestone payments.
| More... |
| 08.03.2010 | Acetylon Licenses Powerful Discovery Methodology and Platform from Harvard University and the Dana-Farber Cancer Institute for Development of Further Next-Generation Class II-Selective HDAC Inhibitor Compounds
Acetylon
Pharmaceuticals today announced an exclusive therapeutic license for
a robust platform technology and chemical methodology to conduct
high-throughput screening and lead optimization for HDAC inhibitor
compounds, as well as a portfolio of small-molecule selective histone
deacetylase (HDAC) enzyme inhibitors including the first-ever selective
inhibitor of HDAC6. The license was granted to Acetylon by Harvard
University and the Dana-Farber Cancer Institute. Acetylon is currently
focused on the development of potential drug candidates based on next
generation Class II-selective HDAC inhibitors. Class IIB enzymes such as
HDAC6 have emerged as important targets in inflammatory disease,
neurologic disease and broadly in cancer. The platform and methodology
were discovered by two of Acetylon's scientific founders, James
E. Bradner MD of the Dana-Farber Cancer Institute and Ralph
Mazitschek Ph.D., now of the Massachusetts General Hospital, along
with colleagues at Harvard and the Broad Institute of Harvard and MIT.
Acetylon Pharmaceuticals believes that its next-generation, selective
HDAC inhibitor compounds may accomplish enhanced clinical utility by
reducing or eliminating the debilitating and sometimes life-threatening
side effects associated with the current first-generation of
non-selective HDAC inhibitors.
| More... |
| 08.03.2010 | Alliance for Regenerative Medicine (ARM) to Participate at the 2010 World Stem Cell Summit in Detroit
The Genetics Policy Institute (GPI) www.genpol.org
, producer of the 2010 World Stem Cell Summit, announced that the
Alliance for Regenerative Medicine (ARM) www.alliancerm.org
will be an educational partner of the 2010 Summit, taking place in
Detroit, Michigan on October-4-6. Several ARM leaders will contribute
presentations focusing on policy and industry issues relating to
regenerative medicine.
| More... |
| 08.03.2010 | Medica Research Institute Launched
Medica today announced the launch of the Medica Research Institute as a
non-profit company that will serve as the research arm within the
broader organization. Built on the principals of systematic
investigation, some potential areas of study include health services
research, comparative effectiveness research and clinical trial studies.
| More... |
| 08.03.2010 | Gannett offers promotional support to help military members and veterans
Gannett (NYSE:GCI) is offering promotional support to ClearChoice Dental
Implant Centers, the No. 1 dental implant provider in the U.S., to help
current members of the military and military veterans who have developed
dental problems related to their service.
| More... |
| 08.03.2010 | Termites Thrive Through All Weather Conditions
As the spring sun begins to shine, we all look forward to putting this
season's very wet weather behind us. According to pest experts, the wet
winter will be a perfect breeding ground for pests, and termites are no
exception. Long considered one of the most prevalent and damaging pests
in the South, termites will cause more than $5 billion in property
damage this year alone. And that damage, says Arrow pest expert Shay
Runion, is not usually covered by homeowners' insurance. Runion
encourages homeowners to learn more about termite
control to protect their most important investment.
| More... |
| 08.03.2010 | Sebelius Sends Letter to Insurance Company CEOs, Calls on Executives to Publicly Justify Premium Hikes
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc.,
Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc.,
U.S. Department of Health and Human Services (HHS) Secretary Kathleen
Sebelius called on the executives to publicly justify proposed health
insurance premium increases. Sebelius' letter comes after a meeting last
week with these executives at the White House.
| More... |
| 08.03.2010 | Anika Therapeutics to Webcast Presentation at Canaccord Adams Musculoskeletal Conference
Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that Charles
Sherwood, president and chief executive officer, will be presenting at
the Canaccord Adams Musculoskeletal Conference on Tuesday, March 9, 2010
at 9:00 a.m. CT (10:00 a.m. ET). A live audio webcast of the
presentation may be accessed via the Internet at:
http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2953940.
In addition, the presentation will be available live at the "Investors"
section of Anika's website at www.anikatherapeutics.com.
Dr. Sherwood will be discussing the current state of the business,
including the Company's recent acquisition of Fidia Advanced Biopolymers.
| More... |
| 08.03.2010 | Corning Announces Lab for the Cure Program
Corning Incorporated (NYSE: GLW) today announced the Corning
Lab for the Cure program, a first-of-its-kind corporate sponsorship
agreement with Susan
G. Komen for the Cure®. Under terms of the agreement and
through a one-time donation of $250,000, Corning
Life Sciences will engage with Susan G. Komen for the Cure
throughout 2010 in co-marketing and co-branding initiatives to increase
awareness for Komen's promise to save lives and find a cure for breast
cancer.
| More... |
| 08.03.2010 | Aetna Wins Contract for Pennsylvania Medicaid Program
The State of Pennsylvania notified Aetna (NYSE: AET) that it has awarded
a Medicaid managed care contract to Aetna Better Health,SM Aetna's
Medicaid business.
| More... |
| 08.03.2010 | Research and Markets: Global Probiotics Market: Trends and Opportunities
| More... |
| 08.03.2010 | Ventas Announces Improved Outlook on Its Corporate Credit Rating From Standard & Poor's Ratings Services
Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") announced today that
Standard & Poor's Ratings Services ("S&P") has revised the outlook on
the Company's corporate credit rating to positive from stable. S&P also
affirmed the Company's current investment grade (BBB-) corporate credit
rating.
| More... |
| 08.03.2010 | Lauth CEO Elected to Second Term of St. Vincent Health Board of Directors
Lauth® Group CEO Robert Lauth, has been elected to his
second term on the board of St. Vincent Health, the state's largest
healthcare employer encompassing 18 health facilities, serving 45
counties in central Indiana and recognized nationally for its exemplary
community service.
| More... |
| 08.03.2010 | Enzon's Debt is Reduced by $116 Million
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the results
from the recent tender and increased conversion periods of the 4 percent
convertible notes due in 2013. As a result of the sale of the specialty
pharmaceutical business on January 29, 2010, the Company was required to
offer to repurchase for cash any and all of its convertible notes at
face value. This offer expired on March 5, 2010 and no notes were
tendered.
| More... |
| 08.03.2010 | Research and Markets: What Health Care Lawyers Need to Know About New Federal HITECH Act Rules and Health Breach Notification Rules Effective in February 2010
| More... |
| 08.03.2010 | Sartorius: Aufsichtsrat und Vorstand schlagen Dividende auf Vorjahreshöhe vor
Aufsichtsrat und Vorstand der Sartorius AG haben in ihrer heutigen
Sitzung beschlossen, der Hauptversammlung am 21. April 2010
vorzuschlagen, eine im Vergleich zum Vorjahr unveränderte Dividende in
Höhe von 0,42 Euro je Vorzugsaktie bzw. 0,40 Euro je Stammaktie
auszuschütten.
| More... |
| 08.03.2010 | Bioness Appoints New President and CEO
Bioness Inc. announces that its Board of Directors named Thomas G.
Fogarty as the company's new President and CEO, effective February 4th.
Fogarty succeeds former President and CEO Yitzhak Zilberman, who has
left the company.
| More... |
| 08.03.2010 | Speakers and Agenda Announced for Healthcare Billing & Management Association 2010 Spring Educational Conference
The Healthcare Billing & Management Association (HBMA),
a non-profit educational resource and advocacy group representing
third-party medical billers and billing professionals, announced today
details of the association's 2010 Spring Educational Conference. This
year's conference takes place at the Baltimore Marriott Waterfront,
April 14-16, 2010, and will provide attendees the opportunity to learn
about recent and imminent changes in the healthcare industry.
| More... |
| 08.03.2010 | New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks
| More... |
| 08.03.2010 | FDA clears biospace med's sterEOS 2D/3D workstation for pediatric use in spine
biospace med (www.biospacemed.com)
announced today that it has received 510(k) clearance from the FDA (Food
and Drug Administration) to market the Company's sterEOS 2D/3D
workstation for pediatric use in spine applications.
The Company's EOS ultra-low-dose imager previously has been
FDA-cleared for use in pediatrics and adults, while sterEOS has
previously been FDA-cleared for adult use in spine.
| More... |
| 08.03.2010 | CIGNA Simplifies Paying Medical Bills for Millions of Customers
| More... |
| 08.03.2010 | RepRegen Reports Potential Advance in the Repair and Regeneration of Hard-Tissue, Such as Bone
RepRegen,
the ‘smart biomaterials' company previously known as BioCeramic
Therapeutics, announced today that data from an in vitro study
has demonstrated that its patented Strontium-based bioactive
glass platform promotes osteoblast cell activity and proliferation. If in
vivo studies, which are currently underway, demonstrate similar
results, then RepRegen believes its platform has the potential to
significantly improve the repair and regeneration of hard-tissue, such
as bone. The in vitro study was presented yesterday in a science
session during the 56th Annual Meeting of the Orthopaedic Research
Society (ORS) by Matthew O'Donnell, Ph.D., R&D Manager for RepRegen.
| More... |
| 08.03.2010 | Part One of a Two Part Audio Interview with Andrew Whelan, CEO of BioElectronics, Inc., is Now at SmallCapVoice.com
| More... |
| 08.03.2010 | HumanaOne Unveils New Individual Vision Insurance Plan on Web Site
| More... |
| 08.03.2010 | Entelos and RegeneMed Introduce iToxFX to Help Predict the Safety of New Drugs
Entelos,
Inc., a simulation and modeling company focused on human
health, and RegeneMed,
Inc., a tissue-based drug discovery and regenerative medicine
company, announced today the release of iToxFX.
| More... |
| 08.03.2010 | John Gatti Named President and Chief Operating Officer of MicroSun Technologies
MicroSun Technologies, an industry leader in customized alternative
power sources for the medical, commercial and military markets,
announced today that John Gatti has joined the company as President and
Chief Operating Officer for the U.S. and Malaysia. Mr. Gatti will also
serve as Executive Vice President and Chief Operating Officer of
MicroSun Electronics.
| More... |
| 08.03.2010 | iCAD Granted U.S. Patent on CAD Lesion Metrics That Enhance Clinical Information for Image Analysis Solutions
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of
advanced image analysis and workflow solutions for the early
identification of cancer, announces that the United States Patent and
Trademark Office recently granted the company Patent Number 7,660,448.
This patent covers future iterations of iCAD's SecondLook®
Digital Computer-Aided Detection (CAD) solution with potential
application to the company's other image analysis solutions. iCAD has
developed and now patented this technology, which incorporates CAD
lesion metrics to provide clinicians with enhanced clinical information.
| More... |
| 08.03.2010 | Precision BioSciences Announces that the US Patent Office Issues Second Actions Rejecting Previously Granted Claims to Cellectis' Core Technology
Precision BioSciences, Inc., today announced that the United States
Patent and Trademark Office (PTO) has issued non-final Actions Closing
Prosecution in the reexamination proceedings for U.S. Pat. Nos.
6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are
owned by the Institut Pasteur and the Universite Pierre et Marie Cure
(UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the
PTO has rejected all claims under consideration as lacking novelty
and/or as obvious in view of a variety of references, including many
that were not provided to the patent examiners during prosecution by the
patent applicants.
| More... |
| 08.03.2010 | Alun Malone Joins Millennium Laboratories As New Business Development Executive
Millennium
Laboratories, Inc., a leading provider of therapeutic drug
monitoring and education to physicians and staff treating chronic pain
patients, announced today that Alun Malone has joined the company as
Business Development Executive. He will be responsible for business
development and implementing strategic initiatives, and will report to
Howard Appel, President of Millennium Laboratories.
| More... |
| 08.03.2010 | Response Genetics Announces $4 Million Private Placement
Response Genetics, Inc. (Nasdaq:RGDX) announced today that it has
entered into a purchase agreement with certain new and existing
investors and certain funds managed by Lansdowne Partners Limited
Partnership to raise approximately $4 million from the private placement
of 3,005,349 newly issued shares of its common stock, at a purchase
price of $1.31 per share. The signing of the purchase agreement occurred
on Friday, March 5, 2010. We expect the final closing of the shares will
occur on Monday, March 8, 2010.
| More... |
| 08.03.2010 | Genta Announces $25 Million Financing
Genta Incorporated (OTCBB: GETA) announced today that the Company has
entered into definitive agreements with institutional investors for a
private placement of Convertible Notes totaling $25 million in gross
proceeds. The transaction is expected to close on or about March 10,
2010, subject to the satisfaction of customary closing conditions.
Proceeds of the financing will be used to ensure adequate followup to
determine overall survival results from Genta's recently completed Phase
3 trial of Genasense® (oblimersen sodium) Injection plus chemotherapy as
first-line treatment of patients with advanced melanoma (known as
AGENDA) and to accelerate development of the Company's pipeline
products, among other uses.
| More... |
| 08.03.2010 | Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis Personalized Immunotherapy Platform in Metastatic RCC at ASCO GU Symposium
Argos Therapeutics today announced the presentation of positive data
from a Phase 2 trial that evaluated the safety, clinical response and
immune response of AGS-003 treatment in newly diagnosed patients with
metastatic renal cell carcinoma (mRCC). The data were discussed March 7
in a poster presentation at the ASCO Genitourinary Cancers Symposium.
AGS-003 is a product of the Company's Arcelis technology, and is a
personalized, RNA-loaded, dendritic cell-based immunotherapy that is
perfectly matched to each patient's unique tumor burden. According to
results from the study, AGS-003 induced a tumor-specific immune
response, performed better than interferon-α on a measure of
progression-free survival, and was well tolerated.
| More... |
| 08.03.2010 | SensAble Technologies Secures $8M Funding to Expand its Digital Dental Restoration Business
SensAble
Technologies, Inc®, a leading provider of 3D modeling software,
haptic devices and dental restoration design and fabrication solutions,
announced that it has received an $8 million investment to propel sales,
marketing and engineering efforts for its digital dentistry product
line. Existing investor HLM
Venture Partners led the round and was joined by North
Bridge Venture Partners, both of whom are headquartered in the
Boston area, and have extensive expertise with medical device company
funding.
| More... |
| 08.03.2010 | DaVita Delivers 20 Presentations at Annual Dialysis Conference
DaVita
Inc. (NYSE: DVA), a leading provider of kidney care services for
those diagnosed with chronic kidney disease (CKD), in conjunction with
DaVita Clinical Research®, today announced that company representatives
will present 20 presentations at the 30th Annual Dialysis
Conference (ADC) scheduled for March 6 9 in Seattle.
| More... |
| 08.03.2010 | KCI Announces Reimbursement Approval in Japan
Kinetic
Concepts, Inc. (NYSE: KCI) today announced it has received
reimbursement approval from Japan's Health Insurance Bureau for use of
the innovative V.A.C. ATS® Therapy System in the country. The
approval signifies an important advancement in the company's plans for
market launch in April and follows Japan's Ministry of Health, Labor and
Welfare's decision in November 2009 to grant final regulatory approval
for the product.
| More... |
| 08.03.2010 | BRAVADA / Muscle Flex® to Continue Its Infomercial Direct Response TV Program Under Its Health and Fitness Brand, Muscle Flex
Muscle Flex Inc. (www.MuscleFlex.com)
(Pink Sheets:MFLI) announced today that it will develop its direct
response television infomercial business exclusively under its health
and fitness brand, Muscle Flex. Muscle Flex will become a "grittier" and
"edgier" health and fitness brand within the company (BRAVADA
International Ltd) that will be marketed to a demographic pre-disposed
to an aggressive health and fitness lifestyle. The direct response
infomercial business shall form an integral part of the Muscle Flex
brand and will utilize a "hard" sales (call to action) approach in the
design, marketing and feel of its DRTV and online marketing strategy.
Through its trademarks and related intellectual properties, the company
unequivocally owns "Muscle Flex" throughout the health and fitness
idioms and believes the best way to maximize on the "Muscle Flex" brand
is to market its products and services exactly as the name suggests; as
an edgy and fitness focused brand. BRAVADA International Ltd will be the
name of the parent company and the BRAVADA brand will engage in
television, media, lifestyle and other related businesses on a macro
scale. Additional details regarding the corporate and brand
configuration shall be provided in a subsequent news release.
| More... |
| 08.03.2010 | Research and Markets: Comprehensive, Superbly Illustrated Textbook of Ophthalmic Disease in Veterinary Medicine
| More... |
| 08.03.2010 | Jericho Systems Participates in OASIS Security Standards Interoperability Showcase at RSA Conference 2010
| More... |
| 08.03.2010 | Quintiles Extends Phase I Capacity and Capabilities
Quintiles today announced the opening of its expanded research facility
in London, UK, increasing its Phase I capacity and extending its ability
to drive progress in translational medicine.
| More... |
| 08.03.2010 | mtm laboratories Announces the European Launch of CINtec® PLUS
mtm laboratories, a privately held diagnostics company today announced
the launch of CINtec® PLUS, the company's next
generation cervical cancer screening product with unmatched accuracy for
the screening and management for cervical cancer. CINtec® PLUS
will be launched with claims direct in Germany, Italy, Spain, France and
the UK, and will also be available in other parts of the world via mtm's
nominated distributors.*
| More... |
| 08.03.2010 | MabCure Completes a Private Placement in the Aggregate Amount of $1 million
MabCure, Inc. (OTCBB:MBCI) ("MabCure"), a biotechnology company using
its proprietary technology to create highly specific monoclonal
antibodies (MAbs) for the early detection of cancer, today announced
that it has recently completed a private placement in the aggregate
amount of $1 million. The amount is comprised of a $500,000 cash
investment and the conversion of a $500,000 bridge loan that was made in
September 2009, into equity securities (together, the "Investment
Transactions").
| More... |
| 08.03.2010 | ikaSystems Technology Helps UPMC Health Plan Implement Quote-to-Card Sales Strategy for Small-Group Employers
UPMC Health Plan, the second-largest health insurer in Western
Pennsylvania, has gone live with ikaPortals, a comprehensive and
integrated series of Web-based solutions from ikaSystems that open the
plan's Web sites to direct small-group sales. Employers with between 2
and 50 employees can register online to evaluate health plan products,
receive quotes, enroll their groups and initiate the member enrollment
process, while their employees can complete their enrollment process —
all online, without generating paper or involving insurance brokers.
| More... |
| 08.03.2010 | PolyMedix to Present at The Roth 22nd Annual Growth Stock Conference
PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com),
an emerging biotechnology company focused on developing new therapeutic
drugs to treat acute cardiovascular disorders and infectious diseases,
will be presenting at the Roth 22nd Annual Growth Stock
Conference. The Conference will take place March 15 17, 2010 at the
Ritz-Carlton Laguna Niguel, CA.
| More... |
| 08.03.2010 | A Majestic Research Study Finds Actemra Will Steal Share in the Rheumatoid Arthritis Market
Results from a study conducted by Majestic
Research suggest that Bristol Myers Squibb's Orencia, Johnson
& Johnson's Remicade, and Amgen's/Wyeth's Enbrel will
forfeit share of the rheumatoid arthritis market to Roche's newly
launched Actemra. Early switching data from Majestic's
proprietary panel of rheumatologists indicates that Orencia may
be the biggest loser of all, as 54% of switches to Actemra thus
far have been from Orencia.
| More... |
| 08.03.2010 | Ricerca Biosciences Finalizes Acquisition of MDS Pharma Services Business
Ricerca
Biosciences, LLC, announced today the finalization of the
acquisition of the Discovery and Preclinical business of MDS
Pharma Services with facilities and almost 600 associates in
Bothell, Washington; Lyon, France; and Taipei, Taiwan.
| More... |
| 08.03.2010 | Research and Markets: Hearing Aid Market Report 2010 - Evolution of Digital Technology Has Changed the Overall Dynamics of the Hearing Aid Industry
| More... |
| 08.03.2010 | Johnson Electric Launches Motors for HVAC Valve Actuators
Johnson
Electric today announced the first of many new electronically
commutated (EC) motors that are under development. This new brushless DC
motor product line is designed for high efficiency, long life and
precision détente torque performance in critical HVAC valve and damper
control applications. http://www.johnsonmotor.com
| More... |
| 08.03.2010 | Bovie Medical Corporation Announces Leonard Keen as General Counsel
Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a
manufacturer and marketer of electrosurgical products, today announced
that it has employed Mr. Leonard Keen, Esq. as Vice President and
General Counsel, effective March 2, 2010. Mr. Keen is responsible for
managing the Company's legal and strategic affairs, and working as a
member of the executive management team to strengthen operations for
growth and competitiveness.
| More... |
| 08.03.2010 | UTSA Opens New Venture Incubator to Nurture Tech Start-Ups
The
University of Texas at San Antonio (UTSA) celebrates the grand
opening of its New Venture Incubator (NVI), a facility with laboratory,
office and meeting spaces to support technology start-ups in the greater
San Antonio region. The incubator, housed on UTSA's Main Campus, will
serve as a bridge between San Antonio entrepreneurs and the region's
research and development community.
| More... |
| 08.03.2010 | Shaquille O'Neal Challenges the Public to Step up and Save a Life
Shaquille O'Neal has teamed up with Be The Match® to tell the
nation about the critical need for more bone marrow donors. In the Do
Something BigSM campaign, the basketball superstar will
challenge Americans to "Be the one to save a life." Three public service
announcements will hit the airwaves and the Internet starting in March.
| More... |
| 08.03.2010 | Rexahn Pharmaceuticals Issued Japanese Patent for Anti-cancer Compound Archexin ®
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage
pharmaceutical company commercializing potential best in class oncology
and CNS therapeutics, today announced that the Japanese Patent Office
has issued a patent for its novel anti-cancer compound, Archexin®.
| More... |
| 08.03.2010 | nanoMR Names Colin Dykes, Ph.D., Chief Scientific Officer
nanoMR, an emerging diagnostic company that develops real-time,
ultrasensitive technology for detecting pathogens in biological samples,
today announced the appointment of Colin W. Dykes, Ph.D., as chief
scientific officer. His primary responsibility will be to establish
studies that validate nanoMR's pathogen detection system in clinical
settings.
| More... |
| 08.03.2010 | CytRx to Present at the Roth Capital Partners OC Growth Stock Conference
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company
specializing in oncology, today announced that CytRx President and CEO
Steven A. Kriegsman and Vice President Business Development David J.
Haen will present at the Roth Capital Partners 22nd Annual OC
Growth Stock Conference on Tuesday, March 16, 2010 at 11:00 a.m. Pacific
time (2:00 p.m. Eastern time). The conference is being held at the Ritz
Carlton in Dana Point, California.
| More... |
| 08.03.2010 | Dr. Sanjiv Argawala to Present Update on Provectus' PV-10
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage
oncology and dermatology biopharmaceutical company, announced today that
Dr. Sanjiv Argawala, Principal Investigator for Provectus' Phase 2 PV-10
trial site at St. Luke's Hospital & Health Network in Bethlehem, PA,
will present an update on the Company's ongoing Phase 2 trial of PV-10
for metastatic melanoma at the Seventh International Symposium on
Melanoma and Other Cutaneous Malignancies on March 12, 2010, in New York
City.
| More... |
| 08.03.2010 | CORRECTING and REPLACING Dr. Sanjiv Agarwala to Present Update on Provectus' PV-10
Please replace the release with the following corrected version due to
multiple revisions.
| More... |
| 08.03.2010 | SuperGen to Present at ROTH Annual OC Growth Stock Conference on March 15th
SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies, today announced
that James S.J. Manuso, Ph.D., President and Chief Executive Officer,
will present at the ROTH 22nd Annual Orange County Growth
Stock Conference on Monday, March 15th in Laguna
Niguel.
| More... |
| 08.03.2010 | TrovaGene, Inc. Announces That Dr. Andreas Braun Has Joined the Company as Its Vice President and Chief Medical Officer
TrovaGene, Inc., a developer of transrenal molecular diagnostics,
announced today that Dr. Andreas Braun has joined the company as its
Vice President and Chief Medical Officer. Dr. Braun has over 25 years of
direct industry experience in developing molecular diagnostic assays for
the clinical reference laboratory.
| More... |
| 08.03.2010 | Mark Farrah Associates Takes Fresh Look at Medigap Market
As Medicare Supplement insurers are positioning to gain market share,
Mark Farrah Associates (MFA) is closely monitoring competitive shifts in
the senior market. New Plans M and N will be introduced on June 1, 2010
and these plans, with lower premiums, are expected to gain traction and
become popular choices among seniors. MFA recently released an analysis
brief about Medigap. Here are some interesting highlights from New
Medicare Opportunities with Medigap.
| More... |
| 08.03.2010 | Comprehensive Online Resource for Soft Tissue Repair Adds New Dynamic Content, Features
In response to its first-ever microsite on advanced soft tissue repair, Cook
Medical has expanded CookBiodesign.com
with new features including Q&A physician videos on biologics and links
to the latest peer-reviewed articles, research and data on its
Biodesign® Advanced Tissue Repair Products. The expanded site now offers
surgeons and patients more than 800 educational resources on Biodesign
products, which have been used in one million procedures and more than
91 countries for the treatment of conditions such as hernia, fistula,
incontinence, pelvic organ prolapse and Peyronie's disease.
| More... |
| 08.03.2010 | University of Michigan Health System Expands Use of Mobile Aspects Tissue Tracking System
Mobile Aspects announced today that the University of Michigan Health
System has signed an agreement to expand the use of its tissue tracking
solution into the Operating Room at the University of Michigan C.S. Mott
Children's Hospital. The solution, called iRISecure, uses the
unique characteristics of radio frequency identification (RFID)
technology to automate clinical workflow associated with tissue
tracking. In turn, a powerful solution is delivered to help care
providers comply with process and procedural requirements from The Joint
Commission and U.S. Food and Drug Administration (FDA) for the
utilization of tissue and related products.
| More... |
| 08.03.2010 | TriZetto Appoints Jeffrey Rideout, M.D. as Senior Vice President, Care and Cost Management, and Chief Medical Officer
The TriZetto Group, Inc. today announced the appointment of Jeffrey
Rideout, M.D., as senior vice president, care and cost management and as
chief medical officer. Dr. Rideout will lead the systematic expansion of
TriZetto's cost and quality of care solutions sets, including
value-based benefits, value-based reimbursement and pharmacy utilization
management, to help the company's payer customers drive greater value in
care for members and providers.
| More... |
| 08.03.2010 | Luminetx® Signs National Distribution Agreement with Alliance Medical
Luminetx®, a division of Christie Medical Holdings, Inc. and
recently acquired by Christie Digital Systems USA, Inc., has signed an
exclusive national sales distribution agreement with New Alliance of
Independent Medical Distributors, Inc., DBA Alliance Medical. The
agreement, effective last month, aligns the medical device company with
Alliance Medical, the nation's largest consortium of specialty medical
sales distribution companies for intravenous devices, with comprehensive
access to the U.S. acute, oncology and home health markets.
| More... |
| 08.03.2010 | Graceway Announces Journal of the American Academy of Dermatology Publishes Articles on New Short-Course Imiquimod Formulation in Actinic Keratosis
The Journal of the American Academy of Dermatology (JAAD) has
published Phase III data evaluating the safety and efficacy of imiquimod
cream at two doses 2.5% and 3.75% administered daily on either
2-week or 3-week treatment cycles. While all study arms met the primary
endpoint of complete clearance versus placebo, data suggest that, of the
regimens studied, imiquimod 3.75% on a 2-week cycle is superior in
treating actinic keratosis (AK) on a large surface area - the full face
or balding scalp. AKs are considered to be the earliest stage in the
development of skin cancer and have the potential to progress to
squamous cell carcinoma (SCC).
| More... |
| 08.03.2010 | Fluidigm Releases 5kb and 10kb Long-Range PCR Protocol for Access Array Systems
Fluidigm Corporation today announced the release of 5kb and 10kb
long-range PCR protocols for its Access Array System. Researchers
interested in targeted re-sequencing projects for large cohort studies
can use these new protocols and the Fluidigm Access Array System to
amplify up to 48 samples per array. Long-range PCR enables new
applications on the Access Array System by allowing researchers to
enrich significantly more sequence per sample.
| More... |
| 08.03.2010 | Research and Markets: "Ischaemic Heart Disease, 1st Revised Edition" Will Provide the Clinically Relevant Information Needed by Today's Practitioners
| More... |
| 08.03.2010 | Butler Health System Selects Alpha Systems for Enterprise Electronic Document Management (EDM)
Alpha Systems, a premier provider of electronic data and document
management solutions, today announced that Butler Health System
(Butler), an innovative healthcare provider located in Pennsylvania, has
named Alpha Systems their vendor of choice for enterprise electronic
document management (EDM) software. This move is designed to improve
Butler's communication across the enterprise while moving the healthcare
provider closer to a paperless environment.
| More... |
| 08.03.2010 | Hooper Holmes Announces 2009 Fourth-Quarter Earnings Release Date and Conference Call Information
Hooper Holmes (NYSE AMEX: HH) today announced that it will
release fourth-quarter financial results before the market opens on
Friday, March 12, 2010. The Company will host a conference call on
Friday, March 12, 2010 at 11:00 a.m. Eastern Time.
| More... |
| 08.03.2010 | ZIOPHARM Oncology to Present at the 22nd Annual Roth OC Growth Stock Conference
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan
Lewis, MD, PhD, Chief Executive Officer, will present at the 22nd
Annual Roth OC Growth Stock Conference on Monday, March 15, 2010 at 4:00
pm PT at the Ritz Carlton / Laguna Niguel, CA. Dr. Lewis will provide an
overview of the Company and its clinical development programs.
| More... |
| 08.03.2010 | RedBrick Health's New, Innovative Health Assessment Platform Generates Broad-Based Employee Engagement
RedBrick
Health, the Health EarningsSM company, today announced
promising early 2010 health engagement results for several new clients.
| More... |
| 08.03.2010 | ExonHit and bioMérieux Decide Not to Pursue Colon Cancer Program
ExonHit Therapeutics (Paris:ALEHT) and bioMérieux have decided not to
pursue their collaboration in colon cancer, following a recent review of
data by their scientific committee. Both companies continue to
collaborate in the field of prostate cancer.
| More... |
| 08.03.2010 | LUNA® Launches First Organic Protein Bar for Women
LUNA®, the maker of the Whole Nutrition Bar for Women®, introduces LUNA®
Protein, the first high protein bar for women made with entirely natural
and organic ingredients. It is an indulgent treat that satiates hunger
and helps women more easily fit protein into their diet.
| More... |
| 08.03.2010 | Depomed to Present at the ROTH 22nd Annual OC Growth Stock Conference
Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief
executive officer, Carl A. Pelzel will be presenting at the ROTH 22nd
Annual OC Growth Stock Conference in Laguna Niguel, CA on March 15, 2010
at 10:00 am PT.
| More... |
| 08.03.2010 | John Muir Medical Center Auxiliary Gives $1 Million Toward $2.5 Million Pledge
John Muir Health Foundation, the charitable fundraising organization for
all John Muir Health programs and services, has received a $1 million
installment from the John Muir Medical Center Auxiliary, Walnut Creek
towards their $2.5 million Capital Campaign pledge to support the
current $621 million hospital expansion at the Walnut Creek Campus. In
recognition of their leadership Campaign gift, a central rotunda in the
new patient care tower will be named in honor of the Auxiliary.
| More... |
| 08.03.2010 | Spring Cleaning Spruces up Your Home and Helps Your Mental Health Shine
The month of March brings with it the official start of spring a
season associated with renewal and romance, and, on a less lyrical level
with dusting, scrubbing, and otherwise engaging in the
roll-up-your-sleeves ritual known as spring cleaning. While heavy-duty
housework hardly sounds inviting, Health
Net, Inc. (NYSE: HNT) wants to spread the word that spring cleaning
not only results in a tidy abode, but also brings with it mental health
benefits.
| More... |
| 08.03.2010 | Intermountain Healthcare and Toshiba Announce Ultrasound Substudy of faCTor64 Speckle Tracking by Echo
Cardiovascular death is the most common cause of mortality among Type 2
diabetics and claims the lives of millions each year, with many
diabetics experiencing their first "symptom" as a heart attack or sudden
death. Understanding that diabetics are at high risk for Coronary Heart
Disease (CHD) and that many with the disease are asymptomatic, Toshiba
America Medical Systems, Inc., has sponsored Speckle Tracking by Echo, a
faCTor64 substudy using Toshiba's Wall Motion Tracking
ultrasound technology. faCTor64 is a landmark study with
Intermountain Healthcare to assess asymptomatic diabetics using cardiac
CT angiography (CTA) with the Toshiba Aquilion® 64 CT
multi-detector row system.
| More... |
| 08.03.2010 | Charles River to Present at Cowen and Raymond James Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at the Cowen and Company 30th
Annual Health Care Conference in Boston, Massachusetts on Wednesday,
March 10th, at 10:15 a.m. ET and the Raymond James 31st
Annual Institutional Investors Conference in Orlando, Florida on
Wednesday, March 10th, at 11:00 a.m. ET. Management will
present an overview of Charles River's strategic focus and business
developments.
| More... |
| 07.03.2010 | Press Registration Available for Integrated Healthcare Association Sponsors 5th Annual National Pay for Performance (P4P) Summit
| More... |
| 07.03.2010 | Life Time Fitness Establishes New Guinness World Record Set for Largest Static Cycling Class
Minneapolis' Target Center Arena was transformed into the world's
largest cycling class today with the "Ride of a Lifetime." Hosted by
Life Time Fitness (NYSE:LTM), the event was officially certified as a
new Guinness World Record by Guinness Official, Kimberly Partrick, who
attended the event and made the live post-event proclamation.
| More... |
| 06.03.2010 | MDI Executives To Present at CFO Rising Conference Discussion Entitled Rx For Healthcare
MDI Healthcare Solutions, Inc., announced today that two of the
company's senior executives will present a roundtable discussion at the
prestigious CFO Rising Conference, Navigating The New Normal on
Tuesday, March 9th in Orlando FL. The discussion, entitled,
Rx for Health Care: Why an Integrated Approach to Health Care Spend Can
Lower Costs will be presented by Andy Dengos, SVP
of Sales & Business Development and Rick Farris, VP of Sales.
| More... |
| 06.03.2010 | Apolo Anton Ohno Visits Greenwood Athletic Club to Promote The Century Council's Ask, Listen, Learn Program
The most decorated U.S. Winter Olympian in history and star of the 2010
Winter Olympic Games, Apolo
Anton Ohno has partnered with The
Century Council and its Ask,
Listen, Learn: Kids
and Alcohol Don't Mix program. Today in Greenwood
Village, Ohno, in conjunction with the newly formed Apolo Anton Ohno
Foundation, began a five-city tour to schools throughout the U.S.
encouraging kids to say "YES" to a healthy lifestyle and "NO" to
underage drinking. The Apolo Anton Ohno Foundation, established by the
eight-time Olympic medalist, will focus on providing youth of all ages
and socio-economic backgrounds with the opportunity to play sports, be
active and learn about the benefits of making responsible and positive
choices.
| More... |
| 06.03.2010 | TODAY: Nat'l AHF/Magic Johnson HIV Testing Tour Arrives in Jacksonville
| More... |